KR20120005876A - Calysethc R1 gene derived from red pepper plants involved in the defense reaction of plants and its use - Google Patents
Calysethc R1 gene derived from red pepper plants involved in the defense reaction of plants and its use Download PDFInfo
- Publication number
- KR20120005876A KR20120005876A KR1020100066561A KR20100066561A KR20120005876A KR 20120005876 A KR20120005876 A KR 20120005876A KR 1020100066561 A KR1020100066561 A KR 1020100066561A KR 20100066561 A KR20100066561 A KR 20100066561A KR 20120005876 A KR20120005876 A KR 20120005876A
- Authority
- KR
- South Korea
- Prior art keywords
- calecrk1
- gene
- plant
- plants
- expression
- Prior art date
Links
- 241000196324 Embryophyta Species 0.000 title claims abstract description 106
- 240000004160 Capsicum annuum Species 0.000 title abstract description 14
- 238000006243 chemical reaction Methods 0.000 title abstract description 7
- 230000007123 defense Effects 0.000 title abstract description 5
- 101150106690 R1 gene Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 151
- 230000014509 gene expression Effects 0.000 claims abstract description 51
- 230000028604 virus induced gene silencing Effects 0.000 claims abstract description 31
- 208000015181 infectious disease Diseases 0.000 claims abstract description 26
- 230000001965 increasing effect Effects 0.000 claims abstract description 21
- 239000002773 nucleotide Substances 0.000 claims abstract description 9
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 9
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract description 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 3
- 235000002566 Capsicum Nutrition 0.000 claims description 31
- 239000013598 vector Substances 0.000 claims description 30
- 239000006002 Pepper Substances 0.000 claims description 26
- 235000016761 Piper aduncum Nutrition 0.000 claims description 26
- 235000017804 Piper guineense Nutrition 0.000 claims description 26
- 235000008184 Piper nigrum Nutrition 0.000 claims description 26
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 12
- 239000013603 viral vector Substances 0.000 claims description 7
- 102000018656 Mitogen Receptors Human genes 0.000 claims description 4
- 108010052006 Mitogen Receptors Proteins 0.000 claims description 4
- 239000003112 inhibitor Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 230000026731 phosphorylation Effects 0.000 claims description 3
- 238000006366 phosphorylation reaction Methods 0.000 claims description 3
- 244000203593 Piper nigrum Species 0.000 claims 1
- 241000722363 Piper Species 0.000 abstract description 32
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 10
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 235000002567 Capsicum annuum Nutrition 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 101001065773 Arabidopsis thaliana L-type lectin-domain containing receptor kinase IV.1 Proteins 0.000 abstract description 7
- 239000001511 capsicum annuum Substances 0.000 abstract description 7
- 230000002829 reductive effect Effects 0.000 abstract description 7
- 230000004665 defense response Effects 0.000 abstract description 5
- 238000009395 breeding Methods 0.000 abstract description 2
- 108010003533 Viral Envelope Proteins Proteins 0.000 abstract 1
- 241000723824 Pepper mild mottle virus Species 0.000 description 28
- 238000003757 reverse transcription PCR Methods 0.000 description 24
- 230000004044 response Effects 0.000 description 21
- 101710132601 Capsid protein Proteins 0.000 description 19
- 101710094648 Coat protein Proteins 0.000 description 19
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 19
- 101710125418 Major capsid protein Proteins 0.000 description 19
- 101710141454 Nucleoprotein Proteins 0.000 description 19
- 101710083689 Probable capsid protein Proteins 0.000 description 19
- 239000002299 complementary DNA Substances 0.000 description 17
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 16
- 238000011081 inoculation Methods 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 14
- 238000013518 transcription Methods 0.000 description 13
- 230000035897 transcription Effects 0.000 description 13
- 101150083464 CP gene Proteins 0.000 description 12
- 241000700605 Viruses Species 0.000 description 11
- 238000009825 accumulation Methods 0.000 description 11
- 150000001413 amino acids Chemical group 0.000 description 11
- 230000011664 signaling Effects 0.000 description 11
- 241000723573 Tobacco rattle virus Species 0.000 description 10
- 230000003902 lesion Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 238000010186 staining Methods 0.000 description 9
- 102000001253 Protein Kinase Human genes 0.000 description 8
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 108060006633 protein kinase Proteins 0.000 description 8
- 238000002493 microarray Methods 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 108020004459 Small interfering RNA Proteins 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000004055 small Interfering RNA Substances 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 230000009385 viral infection Effects 0.000 description 5
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 4
- 241000219194 Arabidopsis Species 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 108090001090 Lectins Proteins 0.000 description 4
- 102000004856 Lectins Human genes 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- 241000709992 Potato virus X Species 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000008260 defense mechanism Effects 0.000 description 4
- 230000009368 gene silencing by RNA Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 239000002523 lectin Substances 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 4
- 102000020233 phosphotransferase Human genes 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000002103 transcriptional effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- 108020005345 3' Untranslated Regions Proteins 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 241000208293 Capsicum Species 0.000 description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 3
- 235000007862 Capsicum baccatum Nutrition 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000010240 RT-PCR analysis Methods 0.000 description 3
- 241000723873 Tobacco mosaic virus Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000001728 capsicum frutescens Substances 0.000 description 3
- 239000001390 capsicum minimum Substances 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 108010037850 glycylvaline Proteins 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000013081 phylogenetic analysis Methods 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 102100022887 GTP-binding nuclear protein Ran Human genes 0.000 description 2
- OCRQUYDOYKCOQG-IRXDYDNUSA-N Gly-Tyr-Phe Chemical compound C([C@H](NC(=O)CN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 OCRQUYDOYKCOQG-IRXDYDNUSA-N 0.000 description 2
- 108050008339 Heat Shock Transcription Factor Proteins 0.000 description 2
- 101000774835 Heteractis crispa PI-stichotoxin-Hcr2o Proteins 0.000 description 2
- 101000620756 Homo sapiens GTP-binding nuclear protein Ran Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- PFPUFNLHBXKPHY-HTFCKZLJSA-N Ile-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)N PFPUFNLHBXKPHY-HTFCKZLJSA-N 0.000 description 2
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 2
- 102000003820 Lipoxygenases Human genes 0.000 description 2
- 108090000128 Lipoxygenases Proteins 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000758706 Piperaceae Species 0.000 description 2
- 108700001094 Plant Genes Proteins 0.000 description 2
- 108050002122 Protein kinase domains Proteins 0.000 description 2
- 102000012515 Protein kinase domains Human genes 0.000 description 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 2
- 108091030071 RNAI Proteins 0.000 description 2
- 101100393821 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GSP2 gene Proteins 0.000 description 2
- 108091027967 Small hairpin RNA Proteins 0.000 description 2
- 241000702295 Tomato golden mosaic virus Species 0.000 description 2
- MTEQZJFSEMXXRK-CFMVVWHZSA-N Tyr-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N MTEQZJFSEMXXRK-CFMVVWHZSA-N 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 108091036078 conserved sequence Proteins 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000008121 plant development Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000001124 posttranscriptional effect Effects 0.000 description 2
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910010271 silicon carbide Inorganic materials 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- CWFMWBHMIMNZLN-NAKRPEOUSA-N (2s)-1-[(2s)-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CWFMWBHMIMNZLN-NAKRPEOUSA-N 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
- 101150033839 4 gene Proteins 0.000 description 1
- YWWATNIVMOCSAV-UBHSHLNASA-N Ala-Arg-Phe Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YWWATNIVMOCSAV-UBHSHLNASA-N 0.000 description 1
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 1
- PAIHPOGPJVUFJY-WDSKDSINSA-N Ala-Glu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PAIHPOGPJVUFJY-WDSKDSINSA-N 0.000 description 1
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 1
- HQJKCXHQNUCKMY-GHCJXIJMSA-N Ala-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C)N HQJKCXHQNUCKMY-GHCJXIJMSA-N 0.000 description 1
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- XHNLCGXYBXNRIS-BJDJZHNGSA-N Ala-Lys-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XHNLCGXYBXNRIS-BJDJZHNGSA-N 0.000 description 1
- FQNILRVJOJBFFC-FXQIFTODSA-N Ala-Pro-Asp Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N FQNILRVJOJBFFC-FXQIFTODSA-N 0.000 description 1
- WQLDNOCHHRISMS-NAKRPEOUSA-N Ala-Pro-Ile Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WQLDNOCHHRISMS-NAKRPEOUSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- XQNRANMFRPCFFW-GCJQMDKQSA-N Ala-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)N)O XQNRANMFRPCFFW-GCJQMDKQSA-N 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 101100399934 Arabidopsis thaliana LECRKS5 gene Proteins 0.000 description 1
- KMSHNDWHPWXPEC-BQBZGAKWSA-N Arg-Asp-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KMSHNDWHPWXPEC-BQBZGAKWSA-N 0.000 description 1
- TTXYKSADPSNOIF-IHRRRGAJSA-N Arg-Asp-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O TTXYKSADPSNOIF-IHRRRGAJSA-N 0.000 description 1
- RKQRHMKFNBYOTN-IHRRRGAJSA-N Arg-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N RKQRHMKFNBYOTN-IHRRRGAJSA-N 0.000 description 1
- OOIMKQRCPJBGPD-XUXIUFHCSA-N Arg-Ile-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O OOIMKQRCPJBGPD-XUXIUFHCSA-N 0.000 description 1
- OGSQONVYSTZIJB-WDSOQIARSA-N Arg-Leu-Trp Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O OGSQONVYSTZIJB-WDSOQIARSA-N 0.000 description 1
- FVBZXNSRIDVYJS-AVGNSLFASA-N Arg-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N FVBZXNSRIDVYJS-AVGNSLFASA-N 0.000 description 1
- YFHATWYGAAXQCF-JYJNAYRXSA-N Arg-Pro-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YFHATWYGAAXQCF-JYJNAYRXSA-N 0.000 description 1
- MEFGKQUUYZOLHM-GMOBBJLQSA-N Asn-Arg-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MEFGKQUUYZOLHM-GMOBBJLQSA-N 0.000 description 1
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 1
- IOTKDTZEEBZNCM-UGYAYLCHSA-N Asn-Asn-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOTKDTZEEBZNCM-UGYAYLCHSA-N 0.000 description 1
- ZDOQDYFZNGASEY-BIIVOSGPSA-N Asn-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N)C(=O)O ZDOQDYFZNGASEY-BIIVOSGPSA-N 0.000 description 1
- XQQVCUIBGYFKDC-OLHMAJIHSA-N Asn-Asp-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XQQVCUIBGYFKDC-OLHMAJIHSA-N 0.000 description 1
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 1
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 1
- YGHCVNQOZZMHRZ-DJFWLOJKSA-N Asn-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)N)N YGHCVNQOZZMHRZ-DJFWLOJKSA-N 0.000 description 1
- GQRDIVQPSMPQME-ZPFDUUQYSA-N Asn-Ile-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O GQRDIVQPSMPQME-ZPFDUUQYSA-N 0.000 description 1
- JQBCANGGAVVERB-CFMVVWHZSA-N Asn-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N JQBCANGGAVVERB-CFMVVWHZSA-N 0.000 description 1
- NCFJQJRLQJEECD-NHCYSSNCSA-N Asn-Leu-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O NCFJQJRLQJEECD-NHCYSSNCSA-N 0.000 description 1
- RTFWCVDISAMGEQ-SRVKXCTJSA-N Asn-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N RTFWCVDISAMGEQ-SRVKXCTJSA-N 0.000 description 1
- LSJQOMAZIKQMTJ-SRVKXCTJSA-N Asn-Phe-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LSJQOMAZIKQMTJ-SRVKXCTJSA-N 0.000 description 1
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
- VZNOVQKGJQJOCS-SRVKXCTJSA-N Asp-Asp-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VZNOVQKGJQJOCS-SRVKXCTJSA-N 0.000 description 1
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 1
- KQBVNNAPIURMPD-PEFMBERDSA-N Asp-Ile-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KQBVNNAPIURMPD-PEFMBERDSA-N 0.000 description 1
- IVPNEDNYYYFAGI-GARJFASQSA-N Asp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N IVPNEDNYYYFAGI-GARJFASQSA-N 0.000 description 1
- QJHOOKBAHRJPPX-QWRGUYRKSA-N Asp-Phe-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 QJHOOKBAHRJPPX-QWRGUYRKSA-N 0.000 description 1
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 1
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- MHYHLWUGWUBUHF-GUBZILKMSA-N Cys-Val-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CS)N MHYHLWUGWUBUHF-GUBZILKMSA-N 0.000 description 1
- 108010090461 DFG peptide Proteins 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- 101100396994 Drosophila melanogaster Inos gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229940122498 Gene expression inhibitor Drugs 0.000 description 1
- JKPGHIQCHIIRMS-AVGNSLFASA-N Gln-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N JKPGHIQCHIIRMS-AVGNSLFASA-N 0.000 description 1
- ZNZPKVQURDQFFS-FXQIFTODSA-N Gln-Glu-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZNZPKVQURDQFFS-FXQIFTODSA-N 0.000 description 1
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 1
- NCWOMXABNYEPLY-NRPADANISA-N Glu-Ala-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O NCWOMXABNYEPLY-NRPADANISA-N 0.000 description 1
- VPKBCVUDBNINAH-GARJFASQSA-N Glu-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O VPKBCVUDBNINAH-GARJFASQSA-N 0.000 description 1
- GLWXKFRTOHKGIT-ACZMJKKPSA-N Glu-Asn-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GLWXKFRTOHKGIT-ACZMJKKPSA-N 0.000 description 1
- ZXQPJYWZSFGWJB-AVGNSLFASA-N Glu-Cys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)N ZXQPJYWZSFGWJB-AVGNSLFASA-N 0.000 description 1
- GYCPQVFKCPPRQB-GUBZILKMSA-N Glu-Gln-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N GYCPQVFKCPPRQB-GUBZILKMSA-N 0.000 description 1
- ZWABFSSWTSAMQN-KBIXCLLPSA-N Glu-Ile-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O ZWABFSSWTSAMQN-KBIXCLLPSA-N 0.000 description 1
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 1
- SWRVAQHFBRZVNX-GUBZILKMSA-N Glu-Lys-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SWRVAQHFBRZVNX-GUBZILKMSA-N 0.000 description 1
- ZIYGTCDTJJCDDP-JYJNAYRXSA-N Glu-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZIYGTCDTJJCDDP-JYJNAYRXSA-N 0.000 description 1
- SYAYROHMAIHWFB-KBIXCLLPSA-N Glu-Ser-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYAYROHMAIHWFB-KBIXCLLPSA-N 0.000 description 1
- RXJFSLQVMGYQEL-IHRRRGAJSA-N Glu-Tyr-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 RXJFSLQVMGYQEL-IHRRRGAJSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- OCQUNKSFDYDXBG-QXEWZRGKSA-N Gly-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OCQUNKSFDYDXBG-QXEWZRGKSA-N 0.000 description 1
- IWAXHBCACVWNHT-BQBZGAKWSA-N Gly-Asp-Arg Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IWAXHBCACVWNHT-BQBZGAKWSA-N 0.000 description 1
- LXXLEUBUOMCAMR-NKWVEPMBSA-N Gly-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)CN)C(=O)O LXXLEUBUOMCAMR-NKWVEPMBSA-N 0.000 description 1
- DTRUBYPMMVPQPD-YUMQZZPRSA-N Gly-Gln-Arg Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DTRUBYPMMVPQPD-YUMQZZPRSA-N 0.000 description 1
- JLJLBWDKDRYOPA-RYUDHWBXSA-N Gly-Gln-Tyr Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 JLJLBWDKDRYOPA-RYUDHWBXSA-N 0.000 description 1
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 1
- UTYGDAHJBBDPBA-BYULHYEWSA-N Gly-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN UTYGDAHJBBDPBA-BYULHYEWSA-N 0.000 description 1
- LRQXRHGQEVWGPV-NHCYSSNCSA-N Gly-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN LRQXRHGQEVWGPV-NHCYSSNCSA-N 0.000 description 1
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 1
- LXTRSHQLGYINON-DTWKUNHWSA-N Gly-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN LXTRSHQLGYINON-DTWKUNHWSA-N 0.000 description 1
- YYXJFBMCOUSYSF-RYUDHWBXSA-N Gly-Phe-Gln Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYXJFBMCOUSYSF-RYUDHWBXSA-N 0.000 description 1
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- RYAOJUMWLWUGNW-QMMMGPOBSA-N Gly-Val-Gly Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O RYAOJUMWLWUGNW-QMMMGPOBSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- 102000000039 Heat Shock Transcription Factor Human genes 0.000 description 1
- SVHKVHBPTOMLTO-DCAQKATOSA-N His-Arg-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O SVHKVHBPTOMLTO-DCAQKATOSA-N 0.000 description 1
- JWTKVPMQCCRPQY-SRVKXCTJSA-N His-Asn-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JWTKVPMQCCRPQY-SRVKXCTJSA-N 0.000 description 1
- TVRMJKNELJKNRS-GUBZILKMSA-N His-Glu-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N TVRMJKNELJKNRS-GUBZILKMSA-N 0.000 description 1
- ZSKJIISDJXJQPV-BZSNNMDCSA-N His-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 ZSKJIISDJXJQPV-BZSNNMDCSA-N 0.000 description 1
- STGQSBKUYSPPIG-CIUDSAMLSA-N His-Ser-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 STGQSBKUYSPPIG-CIUDSAMLSA-N 0.000 description 1
- MDOBWSFNSNPENN-PMVVWTBXSA-N His-Thr-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O MDOBWSFNSNPENN-PMVVWTBXSA-N 0.000 description 1
- HDOYNXLPTRQLAD-JBDRJPRFSA-N Ile-Ala-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)N HDOYNXLPTRQLAD-JBDRJPRFSA-N 0.000 description 1
- MKWSZEHGHSLNPF-NAKRPEOUSA-N Ile-Ala-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N MKWSZEHGHSLNPF-NAKRPEOUSA-N 0.000 description 1
- HVWXAQVMRBKKFE-UGYAYLCHSA-N Ile-Asp-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HVWXAQVMRBKKFE-UGYAYLCHSA-N 0.000 description 1
- DCQMJRSOGCYKTR-GHCJXIJMSA-N Ile-Asp-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O DCQMJRSOGCYKTR-GHCJXIJMSA-N 0.000 description 1
- KUHFPGIVBOCRMV-MNXVOIDGSA-N Ile-Gln-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O)N KUHFPGIVBOCRMV-MNXVOIDGSA-N 0.000 description 1
- YBJWJQQBWRARLT-KBIXCLLPSA-N Ile-Gln-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O YBJWJQQBWRARLT-KBIXCLLPSA-N 0.000 description 1
- NYEYYMLUABXDMC-NHCYSSNCSA-N Ile-Gly-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)N NYEYYMLUABXDMC-NHCYSSNCSA-N 0.000 description 1
- IOVUXUSIGXCREV-DKIMLUQUSA-N Ile-Leu-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IOVUXUSIGXCREV-DKIMLUQUSA-N 0.000 description 1
- XDUVMJCBYUKNFJ-MXAVVETBSA-N Ile-Lys-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N XDUVMJCBYUKNFJ-MXAVVETBSA-N 0.000 description 1
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 1
- SAVXZJYTTQQQDD-QEWYBTABSA-N Ile-Phe-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SAVXZJYTTQQQDD-QEWYBTABSA-N 0.000 description 1
- JODPUDMBQBIWCK-GHCJXIJMSA-N Ile-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O JODPUDMBQBIWCK-GHCJXIJMSA-N 0.000 description 1
- XMYURPUVJSKTMC-KBIXCLLPSA-N Ile-Ser-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N XMYURPUVJSKTMC-KBIXCLLPSA-N 0.000 description 1
- AGGIYSLVUKVOPT-HTFCKZLJSA-N Ile-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N AGGIYSLVUKVOPT-HTFCKZLJSA-N 0.000 description 1
- ANTFEOSJMAUGIB-KNZXXDILSA-N Ile-Thr-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N ANTFEOSJMAUGIB-KNZXXDILSA-N 0.000 description 1
- AUIYHFRUOOKTGX-UKJIMTQDSA-N Ile-Val-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N AUIYHFRUOOKTGX-UKJIMTQDSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 1
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 1
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 1
- KVRKAGGMEWNURO-CIUDSAMLSA-N Leu-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(C)C)N KVRKAGGMEWNURO-CIUDSAMLSA-N 0.000 description 1
- XIRYQRLFHWWWTC-QEJZJMRPSA-N Leu-Ala-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XIRYQRLFHWWWTC-QEJZJMRPSA-N 0.000 description 1
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 1
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 1
- BAJIJEGGUYXZGC-CIUDSAMLSA-N Leu-Asn-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N BAJIJEGGUYXZGC-CIUDSAMLSA-N 0.000 description 1
- MYGQXVYRZMKRDB-SRVKXCTJSA-N Leu-Asp-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN MYGQXVYRZMKRDB-SRVKXCTJSA-N 0.000 description 1
- QCSFMCFHVGTLFF-NHCYSSNCSA-N Leu-Asp-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O QCSFMCFHVGTLFF-NHCYSSNCSA-N 0.000 description 1
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 1
- BTNXKBVLWJBTNR-SRVKXCTJSA-N Leu-His-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O BTNXKBVLWJBTNR-SRVKXCTJSA-N 0.000 description 1
- OYQUOLRTJHWVSQ-SRVKXCTJSA-N Leu-His-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O OYQUOLRTJHWVSQ-SRVKXCTJSA-N 0.000 description 1
- HMDDEJADNKQTBR-BZSNNMDCSA-N Leu-His-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMDDEJADNKQTBR-BZSNNMDCSA-N 0.000 description 1
- ORWTWZXGDBYVCP-BJDJZHNGSA-N Leu-Ile-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC(C)C ORWTWZXGDBYVCP-BJDJZHNGSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- ZRHDPZAAWLXXIR-SRVKXCTJSA-N Leu-Lys-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O ZRHDPZAAWLXXIR-SRVKXCTJSA-N 0.000 description 1
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 description 1
- IDGZVZJLYFTXSL-DCAQKATOSA-N Leu-Ser-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IDGZVZJLYFTXSL-DCAQKATOSA-N 0.000 description 1
- HWMQRQIFVGEAPH-XIRDDKMYSA-N Leu-Ser-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 HWMQRQIFVGEAPH-XIRDDKMYSA-N 0.000 description 1
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KNKHAVVBVXKOGX-JXUBOQSCSA-N Lys-Ala-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KNKHAVVBVXKOGX-JXUBOQSCSA-N 0.000 description 1
- 108010062166 Lys-Asn-Asp Proteins 0.000 description 1
- MKBIVWXCFINCLE-SRVKXCTJSA-N Lys-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N MKBIVWXCFINCLE-SRVKXCTJSA-N 0.000 description 1
- DGWXCIORNLWGGG-CIUDSAMLSA-N Lys-Asn-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O DGWXCIORNLWGGG-CIUDSAMLSA-N 0.000 description 1
- IRRZDAIFYHNIIN-JYJNAYRXSA-N Lys-Gln-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IRRZDAIFYHNIIN-JYJNAYRXSA-N 0.000 description 1
- PAMDBWYMLWOELY-SDDRHHMPSA-N Lys-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O PAMDBWYMLWOELY-SDDRHHMPSA-N 0.000 description 1
- LCMWVZLBCUVDAZ-IUCAKERBSA-N Lys-Gly-Glu Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CCC([O-])=O LCMWVZLBCUVDAZ-IUCAKERBSA-N 0.000 description 1
- VLMNBMFYRMGEMB-QWRGUYRKSA-N Lys-His-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CNC=N1 VLMNBMFYRMGEMB-QWRGUYRKSA-N 0.000 description 1
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 1
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 1
- ZJWIXBZTAAJERF-IHRRRGAJSA-N Lys-Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZJWIXBZTAAJERF-IHRRRGAJSA-N 0.000 description 1
- KJIXWRWPOCKYLD-IHRRRGAJSA-N Lys-Lys-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N KJIXWRWPOCKYLD-IHRRRGAJSA-N 0.000 description 1
- TWPCWKVOZDUYAA-KKUMJFAQSA-N Lys-Phe-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O TWPCWKVOZDUYAA-KKUMJFAQSA-N 0.000 description 1
- LNMKRJJLEFASGA-BZSNNMDCSA-N Lys-Phe-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O LNMKRJJLEFASGA-BZSNNMDCSA-N 0.000 description 1
- JMNRXRPBHFGXQX-GUBZILKMSA-N Lys-Ser-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JMNRXRPBHFGXQX-GUBZILKMSA-N 0.000 description 1
- MDDUIRLQCYVRDO-NHCYSSNCSA-N Lys-Val-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN MDDUIRLQCYVRDO-NHCYSSNCSA-N 0.000 description 1
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- BCRQJDMZQUHQSV-STQMWFEESA-N Met-Gly-Tyr Chemical compound [H]N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BCRQJDMZQUHQSV-STQMWFEESA-N 0.000 description 1
- UROWNMBTQGGTHB-DCAQKATOSA-N Met-Leu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UROWNMBTQGGTHB-DCAQKATOSA-N 0.000 description 1
- FZDOBWIKRQORAC-ULQDDVLXSA-N Met-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCSC)N FZDOBWIKRQORAC-ULQDDVLXSA-N 0.000 description 1
- VYDLZDRMOFYOGV-TUAOUCFPSA-N Met-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCSC)N VYDLZDRMOFYOGV-TUAOUCFPSA-N 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108010066427 N-valyltryptophan Proteins 0.000 description 1
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 101150054548 PR1 gene Proteins 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- HTTYNOXBBOWZTB-SRVKXCTJSA-N Phe-Asn-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N HTTYNOXBBOWZTB-SRVKXCTJSA-N 0.000 description 1
- MRNRMSDVVSKPGM-AVGNSLFASA-N Phe-Asn-Gln Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MRNRMSDVVSKPGM-AVGNSLFASA-N 0.000 description 1
- HTKNPQZCMLBOTQ-XVSYOHENSA-N Phe-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N)O HTKNPQZCMLBOTQ-XVSYOHENSA-N 0.000 description 1
- VUYCNYVLKACHPA-KKUMJFAQSA-N Phe-Asp-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N VUYCNYVLKACHPA-KKUMJFAQSA-N 0.000 description 1
- UNLYPPYNDXHGDG-IHRRRGAJSA-N Phe-Gln-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 UNLYPPYNDXHGDG-IHRRRGAJSA-N 0.000 description 1
- JJHVFCUWLSKADD-ONGXEEELSA-N Phe-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O JJHVFCUWLSKADD-ONGXEEELSA-N 0.000 description 1
- BWTKUQPNOMMKMA-FIRPJDEBSA-N Phe-Ile-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BWTKUQPNOMMKMA-FIRPJDEBSA-N 0.000 description 1
- CWFGECHCRMGPPT-MXAVVETBSA-N Phe-Ile-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O CWFGECHCRMGPPT-MXAVVETBSA-N 0.000 description 1
- METZZBCMDXHFMK-BZSNNMDCSA-N Phe-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N METZZBCMDXHFMK-BZSNNMDCSA-N 0.000 description 1
- INHMISZWLJZQGH-ULQDDVLXSA-N Phe-Leu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 INHMISZWLJZQGH-ULQDDVLXSA-N 0.000 description 1
- BNRFQGLWLQESBG-YESZJQIVSA-N Phe-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O BNRFQGLWLQESBG-YESZJQIVSA-N 0.000 description 1
- AFNJAQVMTIQTCB-DLOVCJGASA-N Phe-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 AFNJAQVMTIQTCB-DLOVCJGASA-N 0.000 description 1
- WEDZFLRYSIDIRX-IHRRRGAJSA-N Phe-Ser-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 WEDZFLRYSIDIRX-IHRRRGAJSA-N 0.000 description 1
- IIEOLPMQYRBZCN-SRVKXCTJSA-N Phe-Ser-Cys Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O IIEOLPMQYRBZCN-SRVKXCTJSA-N 0.000 description 1
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 1
- GOUWCZRDTWTODO-YDHLFZDLSA-N Phe-Val-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O GOUWCZRDTWTODO-YDHLFZDLSA-N 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- AJLVKXCNXIJHDV-CIUDSAMLSA-N Pro-Ala-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O AJLVKXCNXIJHDV-CIUDSAMLSA-N 0.000 description 1
- IWNOFCGBMSFTBC-CIUDSAMLSA-N Pro-Ala-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IWNOFCGBMSFTBC-CIUDSAMLSA-N 0.000 description 1
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 1
- ICTZKEXYDDZZFP-SRVKXCTJSA-N Pro-Arg-Pro Chemical compound N([C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(O)=O)C(=O)[C@@H]1CCCN1 ICTZKEXYDDZZFP-SRVKXCTJSA-N 0.000 description 1
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 1
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 1
- VWXGFAIZUQBBBG-UWVGGRQHSA-N Pro-His-Gly Chemical compound C([C@@H](C(=O)NCC(=O)[O-])NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 VWXGFAIZUQBBBG-UWVGGRQHSA-N 0.000 description 1
- AUQGUYPHJSMAKI-CYDGBPFRSA-N Pro-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 AUQGUYPHJSMAKI-CYDGBPFRSA-N 0.000 description 1
- BRJGUPWVFXKBQI-XUXIUFHCSA-N Pro-Leu-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BRJGUPWVFXKBQI-XUXIUFHCSA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000013381 RNA quantification Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101710118046 RNA-directed RNA polymerase Proteins 0.000 description 1
- 101710155365 RPM1-interacting protein 4 Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- FMDHKPRACUXATF-ACZMJKKPSA-N Ser-Gln-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O FMDHKPRACUXATF-ACZMJKKPSA-N 0.000 description 1
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 1
- MLSQXWSRHURDMF-GARJFASQSA-N Ser-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CO)N)C(=O)O MLSQXWSRHURDMF-GARJFASQSA-N 0.000 description 1
- DJACUBDEDBZKLQ-KBIXCLLPSA-N Ser-Ile-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O DJACUBDEDBZKLQ-KBIXCLLPSA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 1
- JWOBLHJRDADHLN-KKUMJFAQSA-N Ser-Leu-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JWOBLHJRDADHLN-KKUMJFAQSA-N 0.000 description 1
- QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 1
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 1
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- OJRNZRROAIAHDL-LKXGYXEUSA-N Thr-Asn-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OJRNZRROAIAHDL-LKXGYXEUSA-N 0.000 description 1
- KGKWKSSSQGGYAU-SUSMZKCASA-N Thr-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KGKWKSSSQGGYAU-SUSMZKCASA-N 0.000 description 1
- GMXIJHCBTZDAPD-QPHKQPEJSA-N Thr-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N GMXIJHCBTZDAPD-QPHKQPEJSA-N 0.000 description 1
- VGYVVSQFSSKZRJ-OEAJRASXSA-N Thr-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=CC=C1 VGYVVSQFSSKZRJ-OEAJRASXSA-N 0.000 description 1
- LKJCABTUFGTPPY-HJGDQZAQSA-N Thr-Pro-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O LKJCABTUFGTPPY-HJGDQZAQSA-N 0.000 description 1
- GFRIEEKFXOVPIR-RHYQMDGZSA-N Thr-Pro-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O GFRIEEKFXOVPIR-RHYQMDGZSA-N 0.000 description 1
- HUPLKEHTTQBXSC-YJRXYDGGSA-N Thr-Ser-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HUPLKEHTTQBXSC-YJRXYDGGSA-N 0.000 description 1
- YRJOLUDFVAUXLI-GSSVUCPTSA-N Thr-Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O YRJOLUDFVAUXLI-GSSVUCPTSA-N 0.000 description 1
- LVRFMARKDGGZMX-IZPVPAKOSA-N Thr-Tyr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=C(O)C=C1 LVRFMARKDGGZMX-IZPVPAKOSA-N 0.000 description 1
- KPMIQCXJDVKWKO-IFFSRLJSSA-N Thr-Val-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPMIQCXJDVKWKO-IFFSRLJSSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- ADBFWLXCCKIXBQ-XIRDDKMYSA-N Trp-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N ADBFWLXCCKIXBQ-XIRDDKMYSA-N 0.000 description 1
- OCCYDHCUKXRPSJ-SXNHZJKMSA-N Trp-Ile-Gln Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O OCCYDHCUKXRPSJ-SXNHZJKMSA-N 0.000 description 1
- OJKVFAWXPGCJMF-BPUTZDHNSA-N Trp-Pro-Ser Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)N)C(=O)N[C@@H](CO)C(=O)O OJKVFAWXPGCJMF-BPUTZDHNSA-N 0.000 description 1
- VDCGPCSLAJAKBB-XIRDDKMYSA-N Trp-Ser-His Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O)N VDCGPCSLAJAKBB-XIRDDKMYSA-N 0.000 description 1
- FFWCYWZIVFIUDM-OYDLWJJNSA-N Trp-Val-Trp Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O FFWCYWZIVFIUDM-OYDLWJJNSA-N 0.000 description 1
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 1
- DXUVJJRTVACXSO-KKUMJFAQSA-N Tyr-Gln-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N DXUVJJRTVACXSO-KKUMJFAQSA-N 0.000 description 1
- FJBCEFPCVPHPPM-STECZYCISA-N Tyr-Ile-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O FJBCEFPCVPHPPM-STECZYCISA-N 0.000 description 1
- NSGZILIDHCIZAM-KKUMJFAQSA-N Tyr-Leu-Ser Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NSGZILIDHCIZAM-KKUMJFAQSA-N 0.000 description 1
- VTCKHZJKWQENKX-KBPBESRZSA-N Tyr-Lys-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O VTCKHZJKWQENKX-KBPBESRZSA-N 0.000 description 1
- GYBVHTWOQJMYAM-HRCADAONSA-N Tyr-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N GYBVHTWOQJMYAM-HRCADAONSA-N 0.000 description 1
- OKDNSNWJEXAMSU-IRXDYDNUSA-N Tyr-Phe-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(O)=O)C1=CC=C(O)C=C1 OKDNSNWJEXAMSU-IRXDYDNUSA-N 0.000 description 1
- QVYFTFIBKCDHIE-ACRUOGEOSA-N Tyr-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O QVYFTFIBKCDHIE-ACRUOGEOSA-N 0.000 description 1
- YFOCMOVJBQDBCE-NRPADANISA-N Val-Ala-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N YFOCMOVJBQDBCE-NRPADANISA-N 0.000 description 1
- OVLIFGQSBSNGHY-KKHAAJSZSA-N Val-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N)O OVLIFGQSBSNGHY-KKHAAJSZSA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- OTJMMKPMLUNTQT-AVGNSLFASA-N Val-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N OTJMMKPMLUNTQT-AVGNSLFASA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- BZOSBRIDWSSTFN-AVGNSLFASA-N Val-Leu-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](C(C)C)N BZOSBRIDWSSTFN-AVGNSLFASA-N 0.000 description 1
- PHZGFLFMGLXCFG-FHWLQOOXSA-N Val-Lys-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N PHZGFLFMGLXCFG-FHWLQOOXSA-N 0.000 description 1
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 description 1
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 1
- PFMSJVIPEZMKSC-DZKIICNBSA-N Val-Tyr-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PFMSJVIPEZMKSC-DZKIICNBSA-N 0.000 description 1
- ZHWZDZFWBXWPDW-GUBZILKMSA-N Val-Val-Cys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(O)=O ZHWZDZFWBXWPDW-GUBZILKMSA-N 0.000 description 1
- 108050006628 Viral movement proteins Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010031045 aspartyl-glycyl-aspartyl-alanine Proteins 0.000 description 1
- 108010037716 aspartyl-phenylalanyl-leucyl-alanyl-glutamate Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 101150103518 bar gene Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 1
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 108010077158 leucinyl-arginyl-tryptophan Proteins 0.000 description 1
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 108010068488 methionylphenylalanine Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 108010064486 phenylalanyl-leucyl-valine Proteins 0.000 description 1
- 108010018625 phenylalanylarginine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 101150038105 pr gene Proteins 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000018866 regulation of programmed cell death Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 230000019254 respiratory burst Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000021918 systemic acquired resistance Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
- 230000005727 virus proliferation Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Peptides Or Proteins (AREA)
Abstract
본 발명은 식물의 방어반응에 관여하는 고추식물 유래 CalecRK1 유전자 및 그 용도에 관한 것으로, 더욱 구체적으로 서열번호 2의 아미노산 서열을 코딩하는 염기서열을 갖는 고추식물 유래의 CaLecRK1(Capsicum annuum lectin receptor kinase1) 유전자에 관한 것이다.
본 발명에 따르면 지금까지 연구가 거의 되어있지 않은 유전자인 CaLecRK1을 바이러스 유도 유전자 억제(Virus-induced gene silencing; VIGS)를 통해 CaLecRK1이 저항성 기능을 수행함을 발견하였다. 본 발명의 CaLecRK1의 발현을 VIGS를 이용하여 억제 시킬 경우, 바이러스 외피단백질 발현이 증가되고, 감염부위의 저항성민감성반응(hypersensitive resistance; HR)을 감소시키는 것을 확인함으로써, 병에 대한 저항성 품종의 개량 및 육종의 방법으로 CaLecRK1 유전자의 발현을 조절하여 감염 저항성 고추식물체를 제공할 수 있다. 따라서 상기 CaLecRK1 유전자를 이용하여 식물의 방어반응이 증가된 형질전환 식물을 생산할 수 있을 것으로 기대된다.The present invention relates to a pepper plant-derived CalecRK1 gene involved in plant defense reaction and its use, and more particularly to CaLecRK1 ( Capsicum annuum lectin receptor kinase1 ) derived from pepper plant having a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 2. It's about genes.
According to the present invention, CaLecRK1 , which has been rarely studied until now, was found to perform CaLecRK1 through a virus-induced gene silencing (VIGS). When inhibiting the expression of CaLecRK1 of the present invention using VIGS, it was confirmed that viral envelope protein expression was increased and hypersensitive resistance (HR) of the infected site was reduced, thereby improving varieties resistant to disease and The breeding method can regulate the expression of the CaLecRK1 gene to provide an infection-resistant pepper plant. Therefore, it is expected that the CaLecRK1 gene can be used to produce transformed plants with increased plant defense response.
Description
본 발명은 식물의 방어반응에 관여하는 고추식물 유래 CaLecRK1 유전자 및 그 용도에 관한 것으로, 더욱 구체적으로 서열번호 2의 아미노산 서열을 코딩하는 염기서열을 갖는 고추식물 유래의 CaLecRK1(Capsicum annuum lectin receptor kinase1) 유전자에 관한 것이다.
The present invention relates to CaLecRK1 gene derived from red pepper plants involved in the defense reaction of plants, and more particularly, CaLecRK1 derived from red pepper plants having a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 2 ( Capsicum annuum lectin receptor kinase1 ) gene.
식물은 국부의 생물적 및 비생물적 스트레스에서 살아남기 위해 다양한 방어기작을 발전시켜왔다. 식물의 방어 반응은 일반적으로 복수유전자(multiple gene)의 조화된 전사활성화(orchestrated transcriptional activation)와 2차 대사산물의 축적을 일반적으로 포함하고, 종종 과민반응(hypersensitive response; HR)의 활성화와 전신획득저항성(systemic acquired resistance)의 발달을 수반한다 [Ryals et al., 1996 The Plant Cell 8:1809-1819; Dangl and Jones, 2001 Nature 411:826-833]. 이들 유도된 반응이 주어진 식물-병원체 상호작용 동안 신속하고 대등하게 일어날 때, 식물은 질병에 대한 저항성을 가지게 된다. 감염되기 쉬운 식물은 방어기작의 개시가 병원체 감염에 대해 더 느리게 반응한다. 따라서 침입하는 미생물을 적시에 인식하는 것, 그리고 신속하고 효과적으로 방어반응들을 유도하는 것은 저항성의 식물과 감염되기 쉬운 식물사이에서 주요 차이점을 만드는 것으로 보인다 [Yang et al., 1997 Genes Dev. 1;11(13):1621-39].Plants have developed various defense mechanisms to survive local biological and abiotic stresses. Plant defense responses generally include orchestrated transcriptional activation of multiple genes and the accumulation of secondary metabolites, often the activation and systemic acquisition of hypersensitive responses (HR). Accompanied by the development of systemic acquired resistance [Ryals et al., 1996 The Plant Cell 8: 1809-1819; Dangl and Jones, 2001 Nature 411: 826-833. When these elicited reactions occur quickly and equally during a given plant-pathogen interaction, the plant becomes resistant to disease. In susceptible plants, the onset of the defense mechanism responds more slowly to pathogen infection. Thus, the timely recognition of invading microorganisms and the induction of protective responses quickly and effectively seem to make a major difference between resistant and susceptible plants [Yang et al., 1997 Genes Dev. 1; 11 (13): 1621-39.
대표적인 가지과 식물인 고추는 우리나라에서 오래전부터 향신료 또는 양념으로 사용되어온 대표적인 작물로서, 이에 대한 병으로는 바이러스병, 세균병, 진균병 등이 고루 다양하게 보고되어 있는데, 그중 치명적인 것으로 난균류에 의한 역병과 진균에 의한 탄저병 및 세균에 의한 세균성 점무늬병 등을 들 수 있다. 고추에 대한 이러한 식물 병들을 방제하기 위해 지금까지는 농약을 이용한 화학적 방제법이 주로 사용되었다. 그러나 그 독성으로 인하여 병원균뿐만 아니라 주변 생태계의 생물까지도 대량 살상하여 생태계를 파괴시키고 토양과 수질을 오염시키는 폐해가 있어 왔다.Pepper, which is a representative eggplant plant, is a representative crop that has been used as a spice or spice for a long time in Korea, and various diseases such as viral disease, bacterial disease, and fungal disease have been reported. And anthracnose caused by fungi and bacterial spot disease caused by bacteria. Until now, chemical control methods using pesticides have been mainly used to control these plant diseases against peppers. However, due to its toxicity, not only pathogens but also organisms in surrounding ecosystems have been killed in large quantities to destroy ecosystems and pollute soil and water quality.
고추부강(Capsicum annuum L. cv. Bukang)은 담배 모자이크 바이러스나 그 밖의 많은 바이러스에 의해 감염되고 그것에 반응하여 다양한 유전자들을 발현시킨다. 그 중에서도 PMMoV-P0(Pepper mild mottle virus strain P0)에 대해서는 초민감성 반응(hypersensitive response) 등과 같은 방어반응을 일으킨다. Capsicum annuum L. cv. Bukang) is infected by tobacco mosaic virus and many other viruses and expresses various genes in response to it. Among them, PMMoV-P 0 ( Pepper mild mottle virus strain P 0 ) causes a defensive response such as a hypersensitive response.
이에, 본 발명자들은 상기 종래기술들의 문제점들을 극복하기 위하여 예의 연구 노력한 결과, 고추부강과 바이러스의 상호작용에 의한 방어반응에서 상위에 존재하는 유전자를 찾아보고자 마이크로어레이를 이용하여 바이러스 처리시 발현이 증가하는 kinase들을 찾아내었으며, 그 중 상위에 존재할 가능성이 크면서 연구가 많이 되어있지 않은 CaLecRK1 유전자를 선별하여 본 발명은 완성하게 되었다.
Accordingly, the present inventors have made diligent research to overcome the problems of the prior arts, and as a result, the expression was increased during the virus treatment using a microarray to find genes present in the upper part in the defense reaction caused by the interaction of pepper and nasal cavity. The present invention was completed by selecting CaLecRK1 genes, which have not been studied much and are likely to exist at the top.
따라서 본 발명의 주된 목적은 고추식물에서 식물 감염에 대한 저항성에 관여하는 CaLecRK1 유전자 및 그 단백질을 제공하는데 있다.Therefore, the main object of the present invention is to provide CaLecRK1 gene and its protein involved in resistance to plant infection in pepper plants.
본 발명의 다른 목적은 상기 CaLecRK1 유전자 및 그 단백질을 이용한 식물 감염 저항성 증가용 조성물을 제공하는데 있다.
Another object of the present invention to provide a composition for increasing plant infection resistance using the CaLecRK1 gene and its protein.
본 발명의 한 양태에 따르면, 본 발명은 서열번호 2의 아미노산 서열을 코딩하는 염기서열을 갖는 고추렉틴수용체인산화1(Capsicum annuum lectin receptor kinase1; CaLecRK1) 유전자를 제공한다.According to an aspect of the present invention, the present invention provides pepper lectin receptor phosphorylation 1 ( Capsicum) having a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 2 annuum lectin receptor kinase1 ; CaLecRK1 ) gene.
본 발명에 있어서, 상기 염기서열은 서열번호 2의 아미노산 서열을 코딩하는 어떠한 염기서열일 수 있으나, 바람직하게는 서열번호 1의 염기서열인 것을 특징으로 한다.In the present invention, the nucleotide sequence may be any nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 2, preferably characterized in that the base sequence of SEQ ID NO: 1.
본 발명의 다른 양태에 따르면, 본 발명은 서열번호 2의 아미노산 서열을 갖는 고추렉틴수용체인산화1(CaLecRK1) 단백질을 제공한다. 상기 CaLecRK1 단백질의 full-length cDNA는 701개 아미노산의 폴리펩타이드를 코딩한다.
According to another aspect of the present invention, the present invention provides Calicec receptor 1 ( CaLecRK1 ) protein having an amino acid sequence of SEQ ID NO: 2. The full-length cDNA of the CaLecRK1 protein encodes a polypeptide of 701 amino acids.
본 발명의 다른 양태에 따르면, 본 발명은 상기 고추렉틴수용체인산화1(CaLecRK1) 유전자를 도입한 재조합 벡터를 제공한다. 상기 CaLecRK1 유전자가 도입된 재조합 벡터는 도 3에 나타내었다.According to another aspect of the present invention, the present invention provides a recombinant vector introducing the Calicectin receptor 1 ( CaLecRK1 ) gene. The recombinant vector into which the CaLecRK1 gene is introduced is shown in FIG. 3.
본 발명의 CaLecRK1 유전자를 이용하여 식물체의 형질전환용 재조합 벡터를 제조할 수 있다. 상기 재조합 벡터의 제조를 위해, 일반적인 바이너리 벡터(binary vector), 코인테그레이션 벡터(cointegration vector) 또는 T-DNA 부위를 포함하지는 않지만 식물에서 발현될 수 있도록 디자인된 일반 벡터가 사용될 수 있다. 특히, 본 발명에 이용될 수 있는 바이너리 벡터는 아그로박테리움(A. tumefaciens)의 Ti 플라스미드와 함께 존재 시, 식물체를 형질전환 시킬 수 있는 T-DNA의 BR과 BL을 함유하는 어떤 바이너리 벡터도 될 수 있으며, 예컨대 pGA 계열, pCG 계열, pCIT 계열, pGPTV 계열, pBECK2000 계열. BiBAC 계열 및 pGreen 계열 벡터 등을 사용할 수 있다.By using the CaLecRK1 gene of the present invention, a recombinant vector for transforming a plant can be prepared. For the preparation of the recombinant vector, a general vector designed to be expressed in a plant, but not including a general binary vector, a cointegration vector, or a T-DNA site may be used. In particular, the binary vector that can be used in the present invention may be any binary vector containing BR and BL of T-DNA capable of transforming plants when present with the Ti plasmid of Agrobacterium ( A. tumefaciens ). PGAG series, pCG series, pCIT series, pGPTV series, pBECK2000 series. BiBAC series and pGreen series vectors can be used.
또한 상기 발현 벡터는 본 발명의 CaLecRK1 유전자가 도입된 식물체를 효과적으로 선발하기 위한 선발인자로 하이그로마이신 내성 유전자(hygromycin resistant gene) 등의 항생제 내성 유전자, bar 유전자 등의 제초제 저항성 유전자 및 GUS, GFP(green fluorescent protein) 및 LUX(luciferase) 등의 표지유전자 등을 포함할 수 있으며, 식물세포에서 목적유전자의 RNA 염기서열을 생산하게하는 프로모터(promoter), 목적으로 하는 유전자의 정보를 가지고 있는 구조 DNA 염기서열 및 식물세포에서 RNA 염기서열의 3′비번역(nontranslated) DNA 염기서열 등으로 이루어진 구조를 적어도 하나 이상을 포함한다. 또한 상기 벡터는 리포터 분자(예컨대, 루시퍼라아제 및 β-글루쿠로니다아제)를 코딩하는 유전자를 추가로 포함할 수 있다.In addition, the expression vector is an antibiotic resistance gene such as a hygromycin resistant gene, a herbicide resistance gene such as bar gene, GUS, GFP (as a selection factor for effectively selecting a plant to which the CaLecRK1 gene of the present invention is introduced). It may include label genes such as green fluorescent protein (LUX) and luciferase (LUX), and may include a promoter for producing RNA sequences of genes of interest in plant cells, and structural DNA bases having information of genes of interest. And at least one structure consisting of a 3 ′ nontranslated DNA sequence of an RNA base sequence and the like in a plant cell. In addition, the vector may further include a gene encoding a reporter molecule (eg, luciferase and β-glucuronidase).
본 발명의 다른 양태에 따르면, 본 발명은 CaLecRK1 유전자가 도입된 상기 재조합 벡터로 형질전환된 식물체를 제공할 수 있다.
According to another aspect of the present invention, the present invention can provide a plant transformed with the recombinant vector introduced CaLecRK1 gene.
본 발명의 한 양태에 따르면, 본 발명은 상기 CaLecRK1 유전자의 발현 억제제를 유효성분으로 함유하는 식물의 감염 저항성 증가용 조성물을 제공한다.According to an aspect of the present invention, the present invention provides a composition for increasing infection resistance of a plant containing the expression inhibitor of the CaLecRK1 gene as an active ingredient.
본 발명의 조성물은 질병 저항성이 약화된 식물체에 투여할 경우, 유전적 요인 또는 환경적 요인으로 인해 식물체 자신의 유전자의 발현이 저하되어 병 저항성이 약화된 식물체의 빠른 회복을 유도할 수 있으며, 일정 투여량 이상에서는 투여량 효과(dose effect)에 의해 정상상태, 즉 야생형보다 더 높은 질병 저항성 효과를 유도할 수 있다.When the composition of the present invention is administered to a plant with weakened disease resistance, the expression of its own genes may be reduced due to genetic or environmental factors, thereby inducing a rapid recovery of the plant with reduced disease resistance. Above the dose, the dose effect can lead to a steady state, ie higher disease resistant effect than the wild type.
본 발명의 조성물에 있어서, 상기 CaLecRK1 유전자 발현 억제제의 예로는 CaLecRK1 유전자의 RNA 간섭(RNA interference; RNAi)을 이용한 siRNA(short interfering RNA) 또는 shRNA(short hairpin RNA)도 될 수 있으나, 바람직하게는 CaLecRK1 유전자가 도입된 VIGS(Virus-induced gene silencing)용 바이러스 벡터 인 것이 바람직하다.In the composition of the present invention, the CaLecRK1 gene expression inhibitor may be siRNA (short interfering RNA) or shRNA (short hairpin RNA) using RNA interference (RNA interference) of the CaLecRK1 gene, but preferably CaLecRK1 It is preferable that the gene is a viral vector for virus-induced gene silencing (VIGS).
상기 용어 ‘VIGS’는 RNA 바이러스의 복제에 의해 필연적으로 생겨나는 double strand RNA를 인식하여 그것을 저하시키는 식물방어 기작을 이용한 실험방법이다. VIGS는 바이러스 침입시 유전자 염기서열의 상동성에 의존하는데, 바이러스 벡터에 식물체유전자 일부를 도입시켜 식물체에 접종하면 전사 후 유전자 침묵현상과 같거나, 유사한 기작에 의해 도입유전자의 발현이 억제되어 도입유전자의 기능을 분석할 수 있는 방법이다.The term 'VIGS' is an experimental method using a plant defense mechanism that recognizes and degrades double strand RNA inevitably generated by the replication of an RNA virus. VIGS relies on the homology of gene sequences during virus invasion. When a plant gene is introduced into a viral vector and inoculated into a plant, the expression of the transgene is inhibited by a mechanism similar to or after gene transcription. It is a way to analyze the function.
본 발명에 사용될 수 있는 VIGS용 바이러스 벡터는 tobacco rattle virus (TRV), tobacco mosaic virus (TMV), potato virus X (PVX) 그리고 tomato golden mosaic virus (TGMV) 등 VIGS용 바이러스 벡터가 사용될 수 있으나, 바람직하게는 tobacco rattle virus(TRV) 바이러스 벡터가 다른 벡터들의 백화현상, 잎의 찌그러짐, 세포괴사 등의 표현형을 유도하는 문제점과 growing point에 감염되지 않기 때문에 식물발달과 관련된 유전자의 연구에는 부적합하다는 문제점을 극복할 수 있어서 바람직하다. TRV 벡터를 이용해 감염 시킬 경우 가벼운 증상만이 나타나며 growing point에 감염이 가능하기 때문에 식물발달과 관련된 유전자 연구에도 적합하다. 본 발명의 VIGS용 바이러스 벡터는 도 3에 개시된 pTRV2::CaLecRK1인 것을 특징으로 한다. 상기 pTRV2::CaLecRK1 벡터는 CP(coat protein) 및 T(transcriptional terminators)의 벡터 사이트 사이에 존재하는 MCS(multiple cloning site)에 CaLecRK1(2204 ~ 2360 bp)을 삽입하여 제조된다. 도 3에 나타낸 벡터에서, LB는 Left border, Rb는 Right border, 35S는 CaMV 35S promoters, T는 transcriptional terminators, RdRp는 RNA-dependent RNA polymerase, MP는 movement protein, 16K는 16k protein, CP는 coat protein, MCS는 multiple cloning site를 나타낸다.The viral vector for VIGS that can be used in the present invention may be a viral vector for VIGS such as tobacco rattle virus (TRV), tobacco mosaic virus (TMV), potato virus X (PVX) and tomato golden mosaic virus (TGMV), but is preferred. In particular, the tobacco rattle virus (TRV) vector is not suitable for the study of genes related to plant development because it does not induce the phenotype of bleaching, leaf distortion and cell necrosis of other vectors and growing point. It is preferable because it can overcome. Infection with TRV vectors only results in mild symptoms and can be infected at growing points, making it suitable for genetic research related to plant development. The viral vector for VIGS of the present invention is characterized in that pTRV2 :: CaLecRK1 disclosed in FIG. The pTRV2 :: CaLecRK1 vector is prepared by inserting CaLecRK1 ( 2204-2360 bp) into a multiple cloning site (MCS) existing between vector sites of coat protein (CP) and transcriptional terminators (T). In the vector shown in Figure 3, LB is Left border, Rb is Right border, 35S is
상기 용어 ‘RNAi’는 많은 진핵생물에서 보존된 전사후 유전자 조절의 한 방법이다. RNAi는 세포에 존재하는 짧은 이중나선 RNA(dsRNA)분자에 의해 유도된다 [Fire 등 (1998), Nature 391: 806-811]. siRNA 라고도 불리우는 이러한 짧은 dsRNA 분자는 단일가닥으로 분리된 후 RNA-유도 침묵 복합체(RNA induced silencing, RISC)에 결합하여 표적화된 mRNA를 절단하거나 번역을 저해한다 [Elbashir SM 등 (2001), Genes Dev, 15: 188-200].The term 'RNAi' is a method of post-transcriptional gene regulation conserved in many eukaryotes. RNAi is induced by short double-stranded RNA (dsRNA) molecules present in cells (Fire et al. (1998), Nature 391: 806-811). These short dsRNA molecules, also called siRNAs, are separated into single strands and then bind to RNA-induced silencing complexes (RISCs) to cleave targeted mRNAs or inhibit translation [Elbashir SM et al. (2001), Genes Dev, 15: 188-200.
또한 발현 억제제가 siRNA일 경우, siRNA 폴리뉴클레오티드 서열은 발현 조절 서열에 작동 가능하게 연결될 수 있으며, 상기 작동 가능하게 연결된 유전자 서열과 발현 조절 서열은 선택 마커 및 복제 개시점(replication origin)을 같이 포함하고 있는 하나의 발현벡터 내에 포함될 수 있다. 상기 “작동 가능하게 연결(operably linked)” 된다는 것은 적절한 분자가 발현 조절 서열에 결합될 때 유전자 발현을 가능하게 하는 방식으로 연결된 유전자 및 발현 조절 서열일 수 있다. 상기 “발현 조절 서열(expression control sequence)”이란 특정한 숙주 세포에서 작동 가능하게 연결된 폴리뉴클레오티드 서열의 발현을 조절하는 DNA 서열을 의미한다. 그러한 조절 서열은 전사를 실시하기 위한 프로모터, 전사를 조절하기 위한 임의의 오퍼레이터 서열, 적합한 mRNA 리보좀 결합 부위를 코딩하는 서열, 전사 및 해독의 종결을 조절하는 서열을 포함한다.In addition, when the expression inhibitor is siRNA, the siRNA polynucleotide sequence may be operably linked to an expression control sequence, wherein the operably linked gene sequence and the expression control sequence comprise a selection marker and a replication origin together. It can be included in one expression vector. The term “operably linked” may be genes and expression control sequences linked in such a way as to enable gene expression when the appropriate molecule is bound to the expression control sequences. The "expression control sequence" refers to a DNA sequence that controls the expression of a polynucleotide sequence operably linked in a particular host cell. Such regulatory sequences include promoters for carrying out transcription, any operator sequence for regulating transcription, sequences encoding suitable mRNA ribosomal binding sites, and sequences that control termination of transcription and translation.
본 발명에 있어서, 상기 식물 감염(infection)은 PMMoV-P0(Pepper mild mottle virus strain P0)에 의해 유발되는 것을 특징으로 한다.In the present invention, the plant infection (infection) is PMMoV-P 0 ( Pepper mild mottle virus strain P 0 ) is characterized by.
보다 구체적으로, 본 발명에서는 역유전학적인 접근방법으로, TRV에 기초한 VIGS 방법을 이용하였으며, 이때 CaLecRK1 유전자의 억제(suppression)는 식물체에 PMMoV-P0을 처리하였을 때, 대조군 식물체와 비교하여 현저히 높은 PMMoV-P0 CP 유전자의 축적량을 나타내었다. 또한 CaLecRK1 유전자를 억제시킨 식물에 PMMoV-P0를 처리하였을 때, CaLecRK1 유전자를 억제시키지 않은 식물에 비해 초민감성 반응에 의한 병변(lesion)의 수가 현저하게 감소되었다. 이러한 결과는 CaLecRK1 유전자가 식물체에서 저항성 반응에 관여하고 있다는 것을 의미하는 것이며, 이를 이용하여 병충해가 많은 고추의 저항성을 증진시킬 수 있는 유전자로써 CaLecRK1 유전자가 매우 유용하게 사용될 수 있음을 증명하는 것이다.More specifically, in the present invention, as a reverse genetic approach, a TRV-based VIGS method was used, wherein the suppression of CaLecRK1 gene was significantly higher than that of control plants when PMMoV -P 0 was treated in plants. The accumulation of PMMoV-P 0 CP gene is shown. In addition, when PMMoV -P 0 was treated in plants that inhibited the CaLecRK1 gene, the number of lesions due to the hypersensitive response was significantly reduced compared to plants that did not inhibit the CaLecRK1 gene. These results indicate that the CaLecRK1 gene is involved in the resistance response in plants, and demonstrates that the CaLecRK1 gene can be very useful as a gene that can enhance the resistance of peppers with many pests.
본 발명에 따른 상기 조성물은 CaLecRK1 유전자, CaLecRK1 단백질 또는 재조합 벡터 외에 식물제제에 일반적으로 사용되는 안정화제 또는 부형제를 유효성분으로써 더 포함할 수 있다. 구체적으로, CaLecRK1 단백질을 제제로 만들어 식물체에 직접 투여하거나, CaLecRK1 유전자를 상기 공지의 식물 발현용 벡터에 클로닝하여 재조합 벡터를 만든 후, 아그로박테리움(A. tumefaciens)을 통하여 식물체에 형질전환시킴으로써, 식물체 내에서 CaLecRK1 단백질을 발현시켜 이로 인해 발현에 관여하는 유전자들의 발현을 증가시킴으로써, 궁극적으로 고추식물의 저항성을 증가시킬 수 있다.The composition according to the present invention may further comprise a stabilizer or excipient generally used in plant preparations as an active ingredient in addition to the CaLecRK1 gene, CaLecRK1 protein or recombinant vector. Specifically, by making a CaLecRK1 protein as a preparation and administering it directly to a plant, or by cloning the CaLecRK1 gene into a known plant expression vector, a recombinant vector is made, and then transformed into a plant through Agrobacterium ( A. tumefaciens ), By expressing the CaLecRK1 protein in plants, thereby increasing the expression of genes involved in expression, it can ultimately increase the resistance of pepper plants.
또한 상기 조성물은 식물 감염(infection)에 대한 저항성을 부여하는 것을 특징으로 한다. 상기 식물 감염은 예컨대 PMMoV-P0 병원체 등으로부터 유발시킬 수 있다.
In addition, the composition is characterized by imparting resistance to plant infection (infection). The plant infection can be caused, for example, from PMMoV-P 0 pathogens and the like.
이상 설명한 바와 같이, 본 발명에 따르면 지금까지 연구가 거의 되어있지 않은 유전자인 CaLecRK1을 바이러스 유도 유전자 억제(Virus-induced gene silencing; VIGS)를 통해 CaLecRK1이 저항성 기능을 수행함을 발견하였다. 본 발명의 CaLecRK1의 발현을 VIGS를 이용하여 억제 시킬 경우, 바이러스 피복단백질 유전자 발현이 증가되고, 감염부위의 과민성 반응(hypersensitive reponse; HR)을 감소시키는 것을 확인함으로써, 병에 대한 저항성 품종의 개량 및 육종의 방법으로 CaLecRK1 유전자의 발현을 조절하여 감염 저항성 고추식물체를 제공할 수 있다. 따라서 상기 CaLecRK1 유전자를 이용하여 식물의 방어반응이 증가된 형질전환 식물을 생산할 수 있을 것으로 기대된다.
As described above, according to the present invention, CaLecRK1 , which has not been studied so far, was found to perform CaLecRK1 through a virus-induced gene silencing (VIGS). When inhibiting the expression of CaLecRK1 of the present invention using VIGS, it was confirmed that viral coat protein gene expression is increased and hypersensitive reponse (HR) at the infected site is reduced, thereby improving the disease-resistant varieties and CaLecRK1 as a method of breeding The expression of the gene can be regulated to provide an infectious pepper plant. Therefore, it is expected that the CaLecRK1 gene can be used to produce transformed plants with increased plant defense response.
도 1은 5′RACE(Rapid Amplication of cDNA Ends) 수행 원리를 도식화하여 나타낸 것이다.
도 2는 본 발명에 사용된 VIGS(Virus-induced gene silencing) 원리를 도식화하여 나타낸 것이다.
도 3은 CaLecRK1 유전자가 삽입된 재조합 벡터 pTRV2::CaLecRK1을 나타낸 도면이다.
도 4는 상처 스트레스(wound stress) 처리에 따른 cacn14085 유전자의 발현 변화를 RT-PCR로 정량하여 나타낸 것이다.
도 5a는 cacn14085 유전자를 억제시킨 식물 및 억제시키지 않은 식물에 바이러스를 처리할 경우, 초민감성 반응에 의한 병변(lesion) 발생의 변화를 나타낸 것이며, 도 5b는 상기 식물들에서 유전자의 발현 변화를 RT-PCR로 정량하여 나타낸 것이다.
도 6은 5′RACE 수행 후, 얻어낸 유전자의 아가로즈 겔 밴드를 나타낸 것이다.
도 7은 CaLecRK1 유전자의 도메인 구조를 도식화하여 나타낸 것이다.
도 8은 애기장대(Arabidopsis thaliana)의 다른 LecRK들과 CaLecRK1의 아미노산 서열을 정렬하여 나타낸 것이다.
도 9는 CaLecRK1 유전자의 계통 발생적(phylogenetic) 분석 결과를 나타낸 것이다.
도 10은 바이러스 감염 후, 시그널링(signaling)에 관여하는 유전자들의 발현 변화를 RT-PCR로 정량하여 나타낸 것이다.
도 11은 CaLecRK1 유전자의 억제 후, 바이러스를 감염시킨 식물에서, SA(salicylic acid) 시그널링에 관여하는 유전자, MeJA(methyl jasmonate) 시그널링에 관여하는 유전자 및 에틸렌(ethylene) 시그널링에 관여하는 유전자들의 전사 수준을 반정량적 RT-PCR을 수행하여 나타낸 것이다.
도 12는 CaLecRK1 유전자를 억제시킨 식물과 억제시키지 않은 식물에 바이러스를 감염시킨 후, 식물을 관찰한 결과 및 CaLecRK1 유전자, PMMoV-P0 CP(coat protein)의 전사 수준을 반정량적 RT-PCR을 수행하여 나타낸 것이다.
도 13은 CaLecRK1 유전자를 억제시킨 식물과 억제시키지 않은 식물에서 PMMoV-P0 증폭을 RT-PCR을 이용하여 정량화한 것이며, 이후 상기 식물을 바이러스로 감염시킨 후 CaLecRK1 유전자 및 PMMoV-P0 CP(coat protein)의 발현 수준을 반정량적 RT-PCR을 수행하여 나타낸 것이다.
도 14는 CaLecRK1 유전자를 억제시킨 식물과 억제시키지 않은 식물에 바이러스를 감염시킨 후, 상기 식물을 트리판 블루로 염색하여 관찰한 결과 및 반정량적 RT-PCR을 이용하여 CaLecRK1 유전자, PMMoV-P0 CP(coat protein)의 발현 수준을 나타낸 것이다.
도 15는 CaLecRK1 유전자를 억제시킨 식물과 억제시키지 않은 식물에 바이러스를 감염시킨 후, 상기 식물을 DAB로 염색하여 관찰한 결과 및 반정량적 RT-PCR을 이용하여 CaLecRK1 유전자, PMMoV-P0 CP(coat protein)의 발현 수준을 나타낸 것이다.1 is a schematic diagram illustrating the principle of performing 5 'Rapid Amplication of cDNA Ends (RACE).
Figure 2 shows the schematic diagram of the virus-induced gene silencing (VIGS) principle used in the present invention.
3 is a diagram showing a recombinant vector pTRV2 :: CaLecRK1 into which the CaLecRK1 gene is inserted.
Figure 4 shows the quantitative change in the expression of the cacn14085 gene according to wound stress (wound stress) treatment by RT-PCR.
Figure 5a shows the change in lesion incidence due to hypersensitivity response when the virus is treated to plants which inhibited the cacn14085 gene and not to the plant, and Figure 5b shows the change in the expression of the gene in the plants. -Quantified by PCR.
Figure 6 shows the agarose gel band of the gene obtained after 5 'RACE.
Figure 7 shows the domain structure of the CaLecRK1 gene.
Figure 8 shows the alignment of the amino acid sequence of another LecRK and CaLecRK1 of Arabidopsis (Arabidopsis thaliana).
9 shows the results of phylogenetic analysis of the CaLecRK1 gene.
Figure 10 shows the quantitative change in expression of genes involved in signaling after viral infection by RT-PCR.
Figure 11 shows the transcriptional levels of genes involved in salicylic acid signaling, genes involved in methyl jasmonate (MeJA) signaling and genes involved in ethylene signaling in virus-infected plants after inhibition of CaLecRK1 gene. Is shown by performing semiquantitative RT-PCR.
Figure 12 shows that after infecting plants with and without inhibiting the CaLecRK1 gene, the plants were observed and the transcript levels of the CaLecRK1 gene, PMMoV -P 0 CP (coat protein), were performed semi-quantitatively by RT-PCR. It is shown.
FIG. 13 shows that PMMoV -P 0 amplification was quantified using RT-PCR in plants that inhibited and inhibited CaLecRK1 gene, and then the CaLecRK1 gene and PMMoV -P 0 CP (coat) after infection with the virus. protein) expression level is shown by performing semi-quantitative RT-PCR.
Figure 14 after the infection of the virus in the plant that is not inhibited and the plants that suppresses CaLecRK1 gene, CaLecRK1 gene using the result, and semi-quantitative RT-PCR was observed by staining the plant with trypan blue, PMMoV-P 0 CP It shows the expression level of (coat protein).
FIG. 15 shows the results of staining the plants with DAB after inhibiting CaLecRK1 gene and plants without inhibiting the virus, and using CaLecRK1 gene, PMMoV -P 0 CP (coat) using semi-quantitative RT-PCR. protein) expression level.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.
Hereinafter, the present invention will be described in more detail with reference to Examples. Since these examples are only for illustrating the present invention, the scope of the present invention is not to be construed as being limited by these examples.
실시예Example 1. One. DNADNA 마이크로어레이Microarray
발현 분석은 Capsicum annuum 300 K 올리고뉴클레오티드 마이크로어레이(GreenGene Biotech)를 이용하여 수행하였다. 상기 마이크로어레이는 고추의 29,580 유니진(unigene)으로부터 디자인되었다. 상기 유니진 중 24,417 유전자의 방향(direction)은 알려져 있으며, 5,163 유전자의 방향은 알려지지 않았다. 각 유전자들은 6 개의 프로브(probe) 2 블록으로 중복 디자인되었으며, 상기 6 개의 프로브는 각각 센스(sense) 및 안티센스(anti-sense) 방향으로 디자인되었다. 총 350,000 프로브가 디자인 되었다. 프로브의 평균 크기는 75 내지 85 ℃ 온도에서의 조정으로 60-nt이다. 이러한 마이크로어레이는 GreenGene Biotech에서 제조되었다.Expression Analysis Capsicum oligonucleotide annuum 300 K were carried out using the oligonucleotide microarray (GreenGene Biotech). The microarray was designed from 29,580 unigene of red pepper. The direction of 24,417 genes in the unigene is known, and the direction of 5,163 genes is unknown. Each gene was designed redundantly with 6
총 RNA는 PMMoV-P0 및 제어 버퍼(control buffer)를 12, 24, 36 및 48 시간 처리한 고춧잎(pepper leaves)으로부터 준비하였다. 이중가닥 cDNA의 합성을 위해 Superscript Double-Stranded cDNA Synthesis kit(Invitrogen, USA)를 사용하였으며, C3-labeled 타겟 DNA 단편의 합성을 위해 1 μg의 이중가닥 cDNA를 40 μl(1 O.D.)의 Cy3-9mer 프라이머(Sigma-Aldrich, USA)와 혼합하였다. 이후 마이크로어레이는 5 μm 해상도 및 Cy3 신호로 미리 설정해놓은 Genepix 4000B(Axon Instruments)로 스캔하였다. 측정된 신호는 Nimblescan(Nimblegen, USA)으로 디지털화하고 분석하였다.
Total RNA was prepared from pepper leaves treated with PMMoV-P 0 and control buffer for 12, 24, 36 and 48 hours. Superscript Double-Stranded cDNA Synthesis kit (Invitrogen, USA) was used for the synthesis of double stranded cDNA, and 40 μl (1 OD) of Cy3-9mer was added to 1 μg of double stranded cDNA for the synthesis of C3-labeled target DNA fragments. Mixed with primers (Sigma-Aldrich, USA). The microarrays were then scanned with a Genepix 4000B (Axon Instruments) preset with 5 μm resolution and Cy3 signals. The measured signal was digitized and analyzed by Nimblescan (Nimblegen, USA).
실시예Example 2. 식물 재배 및 병원균 접종 2. Plant cultivation and pathogen inoculation
본 발명의 실험에 사용된 고추부강(Capsicum annuum L. cv. Bukang)은 실시에 1에서 사용된 PMMoV-P0에 저항성을 갖는다. Capsicum used in the experiment of the present invention annuum L. cv. Bukang) is resistant to PMMoV-P 0 used in Example 1.
먼저, 상기 고추부강 식물을 16 시간 낮, 8 시간 밤의 광주기(photoperiod)로 23 내지 26 ℃에서 배양하였다. 병원균 접종 및 핵산(nucleic acid) 추출을 위해 약 6주된 식물을 사용하였다. PMMoV-P0은 담배(N. tabacum cv. Samsun)에 감염시켜 증식시켰다. PMMoV-P0을 포함하는 고춧잎들의 수액(sap)은 바이러스 접종 버퍼(0.1 M Tris-HCl pH 8.0, 1 % sodium sulfate)에서 감염된 고춧잎들을 분쇄시킴으로써 얻어내었다. 이후 이를 식물에 접종하기 위해, 바이러스를 포함시킨 상기 수액을 적당량의 카보런덤(carborundum)과 섞어 고춧잎의 표면에 접종하였다. Mock-접종된 식물은 접종 버퍼 및 카보런덤만 처리하였다. 조직 응답을 관찰하기 위해, 두 개의 고춧잎들의 하부를 PMMoV-P0 수액으로 접종하고, 접종한지 10 일 후 상기 수액을 처리하지 않은 고춧잎의 상부를 수확하였다.
First, the pepper pepper plants were incubated at 23 to 26 ° C. with a photoperiod of 16 hours day and 8 hours night. Approximately 6 weeks old plants were used for pathogen inoculation and nucleic acid extraction. PMMoV-P 0 is for tobacco ( N. tabacum cv. Samsun) were infected and expanded. Sap of pepper leaves containing PMMoV-P 0 was obtained by crushing infected pepper leaves in virus inoculation buffer (0.1 M Tris-HCl pH 8.0, 1% sodium sulfate). Then, in order to inoculate the plants, the sap containing the virus was inoculated on the surface of the pepper leaf mixed with an appropriate amount of carborundum. Mock-inoculated plants were treated only with inoculation buffer and carborundum. To observe the tissue response, the bottoms of the two pepper leaves were inoculated with PMMoV-P 0 sap, and 10 days after the inoculation, the tops of the untreated pepper leaves were harvested.
실시예 3. 총 RNA의 추출Example 3. Extraction of Total RNA
고춧잎들을 파우더 형태로 만들기 위해, 액체 질소로 그라인드 하였다. 상기 고춧잎 파우더를 2 ml의 RNA 추출 버퍼(0.2 M Tris-HCl pH 8.0, 0.4 M LiCl2, 25 mM EDTA pH 8.0 및 1 % SDS)내에 옮겼다. 2 ml의 물로 포화된 페놀을 고춧잎 파우더와 버퍼가 담긴 튜브에 첨가하고, 상기 튜브를 격렬하게 교반시켰다. 이후 상기 튜브를 4 ℃에서 15 분 동안 14,000×g으로 원심분리하였다. 상층액을 에탄올로 침전시켰으며, 생성된 펠렛(pellet)을 70% 에탄올(DEPC-treated)로 세척한 후, 4 M LiCl2에 용해시켰다. 이후 재침전 한 후, 펠렛을 DEPC-처리된 증류수로 용해시켜 총 RNA를 얻어내었다.
To make the pepper leaves into powder form, they were ground with liquid nitrogen. The pepper leaf powder was transferred into 2 ml of RNA extraction buffer (0.2 M Tris-HCl pH 8.0, 0.4 M LiCl 2 , 25 mM EDTA pH 8.0 and 1% SDS). Phenol saturated with 2 ml of water was added to a tube containing pepper leaf powder and buffer, and the tube was vigorously stirred. The tube was then centrifuged at 14,000 x g for 15 minutes at 4 ° C. The supernatant was precipitated with ethanol and the resulting pellet was washed with 70% ethanol (DEPC-treated) and then dissolved in 4 M LiCl 2 . After reprecipitation thereafter, the pellet was dissolved in DEPC-treated distilled water to obtain total RNA.
실시예Example 4. 4. RTRT -- PCRPCR 및 반정량적( And semiquantitative ( semiquantitativesemiquantitative ) ) RTRT -- PCRPCR 분석 analysis
먼저 cDNA를 5 μg의 총 RNA, 올리고(dT) 프라이머 또는 랜덤 프라이머 및 슈퍼스크립트 역전사 효소(superscript reverse transcriptase)(Promega, USA)를 이용하여 합성하였다. 반정량적 RT-PCR은 Liu et al.(2002)에 설명된 것과 같이 수행하였다.First, cDNA was synthesized using 5 μg of total RNA, oligo (dT) primer or random primer and superscript reverse transcriptase (Promega, USA). Semiquantitative RT-PCR was performed as described in Liu et al. (2002).
유전자-특이적 프라이머는 하기 표 1(표 1-1 및 1-2)에 나타내었다. CaActin 유전자는 RT-PCR에서 RNA 정량을 위해 내부 표준으로써 사용하였다. 각각의 PCR 생성물은 1% 아가로스 겔 전기이동으로 분리하였으며, 자외선 하에서 에티디움 브로마이드(ethidium bromide)로 시각화하였다. RT-PCR로 증폭된 단편의 농도는 Quantity one(Ver.4.3, Bio-Rad, USA) 및 Multi Gauge(Ver.3.0, Fujifilm, Japan)를 이용하여 분석 및 정량하였다.
Gene-specific primers are shown in Table 1 (Tables 1-1 and 1-2) below. CaActin gene was used as internal standard for RNA quantification in RT-PCR. Each PCR product was separated by 1% agarose gel electrophoresis and visualized with ethidium bromide under ultraviolet light. The concentration of fragments amplified by RT-PCR was analyzed and quantified using Quantity one (Ver.4.3, Bio-Rad, USA) and Multi Gauge (Ver.3.0, Fujifilm, Japan).
[표 1-1. RT-PCR 분석을 위한 유전자 특정 프라이머]Table 1-1. Gene Specific Primer for RT-PCR Analysis]
[표 1-2. RT-PCR 분석을 위한 유전자 특정 프라이머]Table 1-2. Gene Specific Primer for RT-PCR Analysis]
실시예Example 5. 5′ 5. 5 ′ RACERACE 에 의한 On by CaLecRK1CaLecRK1 cDNAcDNA 의 분리 및 유전자 분석Isolation and Genetic Analysis
CaLecRK1 유전자의 단편은 cDNA 라이브러리를 통해 얻어내었다. CaLecRK1 전체 cDNA 클론을 분리하기 위해, PMMoV-P0가 감염된 식물로부터 고추 RNA를 분리하였다. cDNA는 cDNA 증폭 키트(Clontech, USA)를 이용하여 제조사의 지시에 따라 합성하였다. 도 1에 나타낸 것과 같이, 5′RACE(Rapid Amplication of cDNA Ends)를 수행하기 위해, CaLecRK1 kinase 도메인의 보존성이 높은 서열에 대응하는 두 개의 유전자 특정 프라이머(GSP1; 5'-GGCCTGTTGATGCTGAGAACCCAAAGTA-3' 및 GSP2; 5'-TGGTGTTGAACCATTTTTCCCCATT-3')를 어댑터 프라이머와의 접합(conjugation)에서 PCR 증폭을 위해 이용하였다. PCR 증폭은 94 ℃에서 30 초, 68 ℃에서 30 초 및 72 ℃에서 30 초, 30 사이클로 수행하였다. PCR 생성물은 TA 클로닝 벡터(Invitrogen)내에 삽입시키고, 삽입물(insert)을 시퀀싱하였다 [http://dna.macrogen.com/kor/ 참조]. 구조 도메인 예측은 SMART [http://smart.embl-heidelberg.de 참조] 및 Pfam [http:/.pfam.sanger.ac.uk 참조] 데이타베이스를 이용하여 수행하였다. TMHMM [http://www.cbs.dtu.dk/services/TMHMM 참조], SOSUI [http://bp.nuap.nagoya-u.ac.jp/~sosui/ 참조]는 막전위 도메인을 예측하기 위해 사용되었다. 다른 도메인의 예측은 InterProScan [http://www.ebi.ac.uk/Tools/InterProScan/ 참조]를 이용하여 수행하였다.
Fragments of the CaLecRK1 gene were obtained through the cDNA library. To isolate CaLecRK1 whole cDNA clones, pepper RNA was isolated from plants infected with PMMoV -P 0 . cDNA was synthesized using the cDNA amplification kit (Clontech, USA) according to the manufacturer's instructions. As shown in FIG. 1, CaLecRK1 was used to perform Rapid Amplication of cDNA Ends (5′RACE). Two gene specific primers (GSP1; 5'-GGCCTGTTGATGCTGAGAACCCAAAGTA-3 'and GSP2; 5'-TGGTGTTGAACCATTTTTCCCCATT-3') corresponding to the highly conserved sequence of the kinase domain for PCR amplification in conjugation with adapter primers Was used. PCR amplification was carried out in 30 seconds at 94 ° C, 30 seconds at 68 ° C and 30 seconds at 72 ° C. PCR products were inserted into TA cloning vectors (Invitrogen) and inserts were sequenced (see http://dna.macrogen.com/eng/ ). Structural domain predictions were performed using SMART [see http://smart.embl-heidelberg.de ] and Pfam [see http: /. Pfam.sanger.ac.uk] databases. TMHMM [see http://www.cbs.dtu.dk/services/TMHMM ], SOSUI [see http://bp.nuap.nagoya-u.ac.jp/~sosui/ ] to predict membrane potential domains Was used. Prediction of other domains was done using InterProScan [see http://www.ebi.ac.uk/Tools/InterProScan/ ].
실시예 6. VIGS(Virus-induced gene silencing)Example 6. Virus-induced gene silencing (VIGS)
VIGS(Virus-induced gene silencing)는 바이러스에 대항하여 RNA가 매개하는 식물방어 기작의 일종으로 도 2와 같은 원리로 작용한다. VIGS는 전사-후 유전자 억제(Post-transcriptional gene silencing, PTGS)의 일종으로 전사-후(Post-transcriptional), RNA 턴-오버(RNA turnover), 뉴클레오티드 서열-특이적(nucleotide sequence-specific)의 특성을 가진다. VIGS 벡터(vector)로는 PVX(Potato virus X) amplicon 또는 TRV(Tobacco rattle virus)에 식물 유전자를 클로닝하여 사용하는데, 본 발명에서는 Liu et al., (2002) virus-induced gene silencing in tomato. Plant J. 31(6)에 보고된 pTRV1과 pTRV2 벡터를 사용하였다.VIGS (Virus-induced gene silencing) is a kind of RNA-mediated plant defense mechanism against the virus acts on the principle shown in FIG. VIGS is a type of post-transcriptional gene silencing (PTGS), characterized by post-transcriptional, RNA turnover, and nucleotide sequence-specific characteristics. Has As a VIGS vector, plant genes are cloned into PVX (Potato virus X) amplicon or TRV (Tobacco rattle virus), and in the present invention, Liu et al., (2002) virus-induced gene silencing in tomato. The pTRV1 and pTRV2 vectors reported in Plant J. 31 (6) were used.
상기 실시예 5에서 얻은 CaLecRK1 cDNA의 3′UTR 영역인 2204 ~ 2360 bp 영역을 PCR로 증폭하고, TRV 게놈의 일부를 포함하는 pTRV2 벡터의 CP(coat protein)와 T(transcriptional terminators) 사이의 MSC(multiple cloning site)에 클로닝하였다 [Ratcliff et al., 2001]. 진공침윤(Agro-infiltration)을 위해, pTRV1, pTRV2 및 재조합 플라스미드 pTRV2::CaLecRK1을 준비한 후, 급속 냉-해동법(freeze-thaw method)[An et al., 1988]을 통해 Agrobacterium tumefaciens GV3101에 형질전환 시켰다. 상기 재조합 플라스미드 pTRV2::CaLecRK1는 pTRV2의 EcoRⅠ 제한효소 부위에 목적 유전자인 CaLecRK1을 연결시킴으로써 제조하였다 (도 3). 각각의 형질전환된 Agrobacterium tumefaciens은 50 μg/ml의 카나마이신 및 50 μg/ml의 리팜피신이 포함된 YEP에서 28 ℃로 밤새도록 배양하였다. 배양된 세포들은 원심분리(3000 rpm, 15 분, 4 ℃)를 통해 침전시키고, 이를 침투버퍼(20 mM citric acid, 2 % sucrose 및 200 μm acetosyringone pH 5.2)에 현탁시킨 뒤, O.D600 = 0.3의 값을 갖도록 상기 침투버퍼(infiltration buffer)로 농도를 조절하였다. 약 1:1.5의 비율로 pTRV1 및 pTRV2 또는 pTRV2::CalecRK1을 각각 혼합한 뒤, 바늘이 없는 1 ml 주사기를 이용하여 18 ℃, 습도 30%에서 발아시킨 고추 떡잎에 주입하였다.
PCR amplifies the 2204-2360 bp region, 3′UTR region of the CaLecRK1 cDNA obtained in Example 5, and the MSC (CP) between the coat protein (CP) of the pTRV2 vector containing a part of the TRV genome and transcriptional terminators (T) multiple cloning site) (Ratcliff et al., 2001). For Agro-infiltration, pTRV1, pTRV2 and recombinant plasmid pTRV2 :: CaLecRK1 were prepared and then Agrobacterium via freeze-thaw method [An et al., 1988]. Tumefaciens GV3101 was transformed. The recombinant plasmid pTRV2 :: CaLecRK1 was prepared by linking CaLecRK1 , a target gene, to the Eco RI restriction site of pTRV2 (FIG. 3). Each transformed Agrobacterium Tumefaciens were incubated overnight at 28 ° C. in YEP containing 50 μg / ml kanamycin and 50 μg / ml rifampicin. The cultured cells were precipitated by centrifugation (3000 rpm, 15 minutes, 4 ° C.), suspended in an infiltration buffer (20 mM citric acid, 2% sucrose and 200 μm acetosyringone pH 5.2), followed by OD 600 = 0.3 The concentration was adjusted with the infiltration buffer to have a value. PTRV1 and pTRV2 or pTRV2 :: CalecRK1 were respectively mixed at a ratio of about 1: 1.5, and then injected into a pepper cotyledon germinated at 18 ° C. and 30% humidity using a 1 ml syringe without a needle.
실시예Example 7. 7. 시퀀스sequence 정렬 및 계통 발생적( Alignment and phylogenetic ( phylogeneticphylogenetic ) 분석) analysis
애기장대(Arabidopsis)에서 CaLecRK1 및 그것의 동족체(homologue)의 도메인 서열 및 표준길이 단백질은 ClustalW 방법으로 정렬하였으며, 계통 발생적 분석은 Megalign Program(Intelligenetics, USA)으로 수행하였다.
Domain sequences and standard length proteins of CaLecRK1 and its homologues in Arabidopsis were aligned by the ClustalW method, and phylogenetic analysis was performed by the Megalign Program (Intelligenetics, USA).
실시예Example 8. 8. DABDAB (3,3'-(3,3'- diaminobenzidinediaminobenzidine ) 염색) dyeing
과산화 수소(hydrogen peroxide) 축적은 DAB 염색으로 시각화 하였다 [thordal Christensen H et al., 1997]. Hydrogen peroxide accumulation was visualized by DAB staining [thordal Christensen H et al., 1997].
먼저, TRV2 및 CaLecRK1 VIGS 식물잎을 PMMoV-P0로 감염시켰다. 감염 3일 후, 감염된 잎들을 절개하고, 0.1% DAB 용액에 담구었다. 이후, 20 분 동안 진공 침투 후, 시료를 20 시간 동안 상온에서 배양하였다. 염색(stain)은 멈춘 후, 엽록소(chlorophyll)는 10 내지 40 분 동안 96%(v/v) 에탄올로 끓임으로써 제거하였다. 이후 DAB 및 H2O2의 반응 특성인 갈색 점을 분석하였다.
First, TRV2 and CaLecRK1 VIGS plant leaves were infected with PMMoV -P 0 . Three days after infection, infected leaves were dissected and soaked in 0.1% DAB solution. Then, after 20 minutes vacuum infiltration, the sample was incubated at room temperature for 20 hours. After the stain was stopped, chlorophyll was removed by boiling with 96% (v / v) ethanol for 10 to 40 minutes. Afterwards, brown spots, which are reaction characteristics of DAB and H 2 O 2 , were analyzed.
실시예Example 9. 9. 트리판Trypan 블루blue (( trypantrypan blueblue ) 염색) dyeing
식물 조직에서 죽은 식물 세포는 트립판 블루로 염색시킴으로써 시각화하였다. Dead plant cells in plant tissue were visualized by staining with trypan blue.
먼저, TRV2 및 CaLecRK1-VIGS 식물잎을 PMMoV-P0로 감염시켰다. 감염 3일 후, 감염된 식물잎을 트리판 블루(10 g 페놀, 10 ml 글리세롤, 10 ml 젖산, 10 ml 증류수 및 0.02 g 트리판 블루)로 염색시켰다. 감염된 식물잎들을 염색용액(staining solution)으로 10 분 동안 끓이고, 클로랄하이드레이트(chloral hydrate)로 밤새도록 재염색시켰다.
First, TRV2 and CaLecRK1- VIGS plant leaves were infected with PMMoV-P 0 . Three days after infection, infected plant leaves were stained with trypan blue (10 g phenol, 10 ml glycerol, 10 ml lactic acid, 10 ml distilled water and 0.02 g trypan blue). Infected plant leaves were boiled with staining solution for 10 minutes and restained overnight with chloral hydrate.
결과 1. PMMoV-PResult 1.PMMoV-P 00 접종에 의해 조절된 단백질 키나아제(protein kinase)의 확인 Identification of Protein Kinases Regulated by Inoculation
PMMoV-P0 처리에 따라 증가된 단백질 키나아제를 확인하기 위해, Capsicum annuum 300 K 마이크로어레이(GreenGene Biotech, Korea)로 발현 분석을 수행하였다. 총 RNA는 PMMoV-P0 및 제어 버퍼(control buffer)를 12, 24, 36 및 48 시간 처리한 고춧잎(pepper leaves)으로부터 준비하였다. 이후 본 발명자들은 PMMoV-P0에 반응하는 34748 유전자들에 대한 정보를 획득하였다. 상기 유전자들 중, 단백질 키나아제를 암호화하는 434 유전자들을 분리하였으며, 분리된 유전자들 중 PMMoV-P0에 반응하여 발현이 3 배 이상 증가되는 38 단백질 키나아제들을 나타내었다 (표 2). 발현이 증가된 단백질 키나아제들 중, 렉틴 단백질 키나아제(clone ID: cacn14085)는 상기 유전자가 수용체와 같은 키나아제를 암호화하는 유전자에 속하는 유전자이며, 그 기능이 대부분 알려져 있지 않으므로 연구를 위해 선택되었다. 마이크로어레이 결과, cacn14085는 4.32 배 이상 발현이 증가되었다.
To identify protein kinases increased following PMMoV-P 0 treatment, expression analysis was performed with a Capsicum annuum 300 K microarray (GreenGene Biotech, Korea). Total RNA was prepared from pepper leaves treated with PMMoV-P 0 and control buffer for 12, 24, 36 and 48 hours. Then we obtained information about 34748 genes in response to PMMoV-P 0 . Of these genes, 434 genes encoding protein kinases were isolated, showing 38 protein kinases that increased expression more than three times in response to PMMoV-P 0 of the isolated genes (Table 2). Among the protein kinases with increased expression, lectin protein kinase (clone ID: cacn14085 ) was selected for the study because the gene belongs to a gene encoding a kinase such as a receptor, and its function is mostly unknown. As a result of microarray, cacn14085 increased the expression by 4.32 times or more.
[표 2-1. 단백질 키나아제 발현 변화]Table 2-1. Protein Kinase Expression Changes]
[표 2-2. 단백질 키나아제 발현 변화]Table 2-2. Protein Kinase Expression Changes]
결과 2. PMMoV-PResult 2.PMMoV-P 00 접종에 따른 반응에서 In response to inoculation cacn14085cacn14085 의 발현 패턴Expression pattern of
PMMoV-P0 접종에 따른 반응에서 cacn14085의 전사가 유도되는지 관찰하기 위해, 고춧잎을 PMMoV-P0로 감염시키고, 총 RNA는 PMMoV-P0 및 제어 버퍼(control buffer)를 12, 24, 36 및 48 시간 처리한 고춧잎(pepper leaves)으로부터 추출하였다. Mock 접종은 대조군으로써 사용하였다. 접종한지 6 시간 후, cacn14085 전사는 mock 처리 및 바이러스 감염 처리군 모두에서 축적되었다. 또한 상처 스트레스(wounding stress) 하에서 cacn14085 유전자의 발현을 확인하기 위해, RT-PCR을 수행하였다. RT-PCR 측정 결과는 도 4에 나타내었다. cacn14085 유전자는 상처 스트레스에 반응한지 2, 6, 12 시간 후에 발현됨을 확인하였다 (도 4의 (A)). 이는, mock 처리 및 바이러스 감염 처리군 모두에서 초기 cacn14085 전사의 축적이 상처 스트레스에 대한 반응에 의한 것임을 나타낸다. 또한 PMMoV-P0 접종한지 24, 48 시간 후, mock 처리군에 비해 바이러스 감염 고춧잎에서 cacn14085 유전자가 강력하게 유도되었다 (도 4의 (B)). 이러한 결과는 PMMoV-P0 감염에 대한 초민감성 반응(HR) 동안 cacn14085 유전자가 특이적으로 발현되었음을 의미한다. CaPR1 유전자의 발현은 PMMoV-P0 접종에 대한 양성 대조군으로써 관찰하였다. CaPR1 유전자의 강한 발현은 접종한지 24, 48 시간 후에 관찰되었다 (도 4의 (B)).
To observe whether Cacn14085 transcription is induced in response to PMMoV -P 0 inoculation, pepper leaves were infected with PMMoV -P 0 , and total RNA was added to PMMoV-P 0 and
결과 3.
본 발명자들은 EST 클론들로부터 cacn14085 유전자의 일부 서열을 얻어내었다. cacn14085 유전자 서열의 길이는 1754 bp이고, 상기 서열은 3'UTR, 키나아제 도메인 및 일부 렉틴 도메인을 포함한다. PMMoV-P0에 대한 방어 반응에서 상기 유전자의 기능을 확인하기 위해, cacn14085 유전자를 억제시킨 식물을 준비하였다. TRV(Tabacco rattle virus)-기반의 VIGS(virus-induced gene silencing)는 cacn14085 유전자의 발현을 억제시키기 위해 이용하였다 [Liu et al., 2002]. cacn14085 유전자의 3'UTR 157 bp 단편은 VIGS를 위해 사용되었으며, 상기 단편은 특정 프라이머를 통해 합성하였다. 상기 유전자에 대한 특정 프라이머는 하기와 같다.
We obtained some sequences of the cacn14085 gene from the EST clones. The cacn14085 gene sequence is 1754 bp in length, and includes 3'UTR, kinase domain and some lectin domain. In order to confirm the function of the gene in the defense response to PMMoV -P 0 , a plant was prepared in which the cacn14085 gene was suppressed. Tabacco rattle virus (TRV) -based virus-induced gene silencing (VIGS) was used to inhibit the expression of the cacn14085 gene [Liu et al., 2002]. The 3'UTR 157 bp fragment of the cacn14085 gene was used for VIGS, which fragment was synthesized via specific primers. Specific primers for the gene are as follows.
cacn14085cacn14085 유전자 gene
Forward; 5'-TAGCAGCATACATATTACCAACA-3'Forward; 5'-TAGCAGCATACATATTACCAACA-3 '
Reverse; 5'-TGCAGCCCAAAAGAAAA-3'
Reverse; 5'-TGCAGCCCAAAAGAAAA-3 '
상기 cacn14085 유전자에 대한 VIGS를 수행한지 한 달 후, 고춧잎들을 PMMoV-P0로 접종하고, 접종 4 일 후, 상기 고춧잎들을 관찰하였다. 관찰 결과는 도 5에 나타내었다. 도 5의 (A)에 보이는 바와 같이, TRV2 벡터 군과 비교하여 cacn14085를 억제시킨 군에서는 초민감성 병변(HR-lesion)의 수가 현저히 감소되었다. 초민감성 병변은 PMMoV-P0에 대항하여 L-gene에 의해 매개되는 방어 반응으로 나타난다. 특히 TRV2 대조군에서는 39개의 초민감성 병변이 나타났으며, PR1 유전자의 발현 또한 강하게 유도되었다. 또한 cacn14085를 억제시킨 식물들에서는 각각의 유전자 발현 패턴 및 병변의 수가 다르게 관찰되었다. 식물 1은 41개의 초민감성 병변이 나타났으며, 식물 2는 39개, 식물 3은 3 ~ 4개, 식물 4는 1 ~ 2개의 초민감성 병변이 관찰되었다. cacn14085 유전자의 전사 수준은 식물 1에서는 전혀 억제되지 않았으며, 식물 2에서는 54%, 식물 3에서는 66%, 식물 4에서는 73% 억제되었다. cacn14085 유전자의 억제 수준이 증가할수록, 초민감성 병변의 수는 더 감소됨을 확인할 수 있다. 또한 CaPR1의 발현 수준(도 5의 (B))도 cacn14085 억제 수준이 증가할수록 감소되었다.
One month after performing VIGS on the cacn14085 gene, the pepper leaves were inoculated with PMMoV-P 0 , and four days after the inoculation, the pepper leaves were observed. Observation results are shown in FIG. 5. As shown in FIG. 5A, the number of hypersensitive lesions (HR-lesion) was significantly reduced in the group inhibited cacn14085 as compared to the TRV2 vector group. Supersensitive lesions appear as a protective response mediated by L-genes against PMMoV-P 0 . In particular, 39 hypersensitive lesions appeared in the TRV2 control group, and the expression of the PR1 gene was also strongly induced. In addition, different gene expression patterns and the number of lesions were observed in plants that inhibited cacn14085 .
결과 4. 5'-RACE를 이용한
cacn14085의 full-length cDNA를 얻기 위해, 일부 렉틴 도메인의 보존된 서열에 상응하는 두 개의 프라이머(GSP1; 5′- GGCCTGTTGATGCTGAGAACCCAAAGTA-3′ 및 GSP2; 5′-TGGTGTTGAACCATTTTTCCCCATT-3′)를 합성한 후, 5'RACE(rapid amplification of cDNA ends)를 도 1에 나타낸 바와 같이 수행하였다. 5'RACE 결과, 도 6에 나타낸 바와 같이, 본 발명자들은 950 bp의 아가로즈 겔(agerose gel) 밴드를 얻어내었으며, 이후 상기 밴드를 시퀀싱하여, 679 bp의 cacn14085 유전자를 더 발견하였다. cacn14085의 full-length cDNA를 얻어내었으며, 상기 유전자를 CaLecRK1(Capsicum annuum Lectin receptor kinase1)로 명명하였다. CaLecRK1 cDNA의 뉴클레오티드 서열은 2433 bp이고(서열번호 1), 701 아미노산(서열번호 2)의 폴리펩타이드를 암호화하는 ORF(open reading frame)를 포함한다.
To obtain a full-length cDNA of cacn14085 , two primers corresponding to the conserved sequence of some lectin domains (GSP1; 5′-GGCCTGTTGATGCTGAGAACCCAAAGTA-3 ′ and GSP2; 5′-TGGTGTTGAACCATTTTTCCCCATT-3 ′) were synthesized. 'Rapid amplification of cDNA ends (RACE) was performed as shown in FIG. As a result of 5'RACE, as shown in FIG. 6, the present inventors obtained a band of 950 bp agarose gel, and then sequenced the band to further find a cacn14085 gene of 679 bp. It was obtained in the full-length cDNA of cacn14085, and named the gene to CaLecRK1 (Capsicum annuum Lectin receptor kinase1) . The nucleotide sequence of the CaLecRK1 cDNA is 2433 bp (SEQ ID NO: 1) and includes an open reading frame (ORF) encoding a polypeptide of 701 amino acids (SEQ ID NO: 2).
결과 5.
Blast tool을 이용한 CaLecRK1의 단백질 서열 분석으로, CaLecRK1이 N-말단 세포외 렉틴 도메인(아미노산 서열 72 ~ 301), 막전위 도메인(아이노산 서열 318 ~ 338) 및 C-말단 세포질 단백질 키나아제 도메인(아미노산 서열 376 ~ 578)과 같은 3 개의 주요 도메인을 포함하고 있는 것을 확인하였다 (도 7). 상기 C-말단 단백질 키나아제 도메인은 ATP-결합 부위 및 Ser/Thr 단백질 활성 부위를 포함한다. 애기장대(Arabidopsis thaliana)의 다른 LecRK들과 CaLecRK1의 아미노산 정렬을 도 8에 나타내었다. CaLecRK1 계통 발생적 분석 결과, CaLecRK1은 아라비돕시스 렉틴 수용체 키나아제(Arabidopsis Lectin receptor kinase)인 At5g06740(GeneBank Accession no.NM_120757)과 아미노산 수준에서 60% 동일한 결과를 보였다 (도 9).
Protein sequencing of CaLecRK1 using the Blast tool revealed that CaLecRK1 is an N-terminal extracellular lectin domain (amino acid sequences 72 to 301), a membrane potential domain ( inos acid sequences 318 to 338) and a C-terminal cytoplasmic protein kinase domain (amino acid sequence 376). 578), it was confirmed that it includes three major domains (Fig. 7). The C-terminal protein kinase domain comprises an ATP-binding site and a Ser / Thr protein active site. Other LecRK and amino acid alignment of CaLecRK1 of Arabidopsis (Arabidopsis thaliana) are shown in Fig. CaLecRK1 phylogenetic analysis revealed that CaLecRK1 was 60% identical at the amino acid level to At5g06740 (GeneBank Accession no. NM_120757), the Arabidopsis Lectin receptor kinase (FIG. 9).
결과 6. 방어 신호 성분의 발현에 대한
PMMoV-P0에 대한 반응에서 시그널링(signaling)에 관여하는 유전자의 발현 패턴을 확인하기 위해, 본 발명자들은 RT-PCR을 수행하였다.To identify expression patterns of genes involved in signaling in response to PMMoV-P 0 , we performed RT-PCR.
키티네이즈(chitinase)를 암호화하는 Cachi1은 병인(pathogenesis)에 관여하는 단백질의 구성요소이며, CaGlu1은 글루탐산 합성 유전자이며, CaOSM1과 CaOSML은 삼투압농도감지(osmosensory) MAPK를 암호화하는 유전자이며, CaLOX1과 CaLOX2는 리폭시게나아제(lipoxygenase) 유전자이며, CaPDF2 .2는 펩타이드 디포밀라제(deformylase) 유전자이며, CaPR2, CaPR4 및 CaPR5는 병인에 관여하는 단백질들을 암호화하는 구성요소이며, CaRIN4은 RPM1 INTERACTING PROTEIN 4 유전자이며, CaNDR1은 세포막에 존재하는 GPI(glycosylphatidylinositol) 고정 유전자이며, CaNPR1은 PR1의 비-발현자이며, CaPAD4는 PHYTOALEXIN DEFICIENT 4 유전자이며, CaCPR5는 CONSTITUTIVE EXPRESSION OF PR GENE 5, CaCOI1는 CORONATINEINSENSITIVE1 유전자이며, CaJAZ1는 JASMONATE-ZIM-DOMAINPROTEIN1 유전자이며, CaCTR1는 CONSTITUTIVETRIPLERESPONSE1 유전자이며, CaEIN3는 ETHYLENE-INSENSITIVE 3 유전자이며, CaERF는 ERF(ethylene response factor) 유전자이며, CaHSTF는 HSTF(heat shock transcription factor) 유전자이며, elF3와 elF4E는 신장 인자(elongation factor) 유전자이다. Cachi1 , which encodes chitinase, is a component of a protein involved in pathogenesis, CaGlu1 is a glutamic acid synthesis gene, CaOSM1 and CaOSML , which encodes an osmosensory MAPK, CaLOX1 and CaLOX2 is lipoxygenase and (lipoxygenase) gene, CaPDF2 .2 is a peptide depot Millar claim (deformylase) gene, CaPR2, CaPR4 and CaPR5 are components that encode proteins involved in etiology, CaRIN4 is an
유전자 발현 측정 결과, Cachi1, CaGlu1, CaLOX1, CaPDF2.2, CaPR2, CaPR4, CaPR5, CaNPR1, CaPAD4, CaCOI1, CaJAZ1, CaCTR1, CaEIN3, CaERF, 및 CaHSTF 유전자들은 PMMoV-P0에 대한 반응으로 발현이 증가되었다. 상처 처리(wound treatment)에 대한 유전자 발현 분석은 대조군으로써 수행되었다 (도 10). As a result of measuring gene expression, Cachi1 , CaGlu1 , CaLOX1 , CaPDF2.2 , CaPR2 , CaPR4 , CaPR5 , CaNPR1 , CaPAD4 , CaCOI1 , CaJAZ1 , CaCTR1 , CaEIN3 , CaERF , And CaHSTF genes increased expression in response to PMMoV -P 0 . Gene expression analysis for wound treatment was performed as a control (FIG. 10).
이후, 분자 수준에서 CaLecRK1 유전자의 효과를 관찰하기 위해, CaLecRK1를 억제시킨 식물 및 TRV2 벡터 식물(대조군)을 PMMoV-P0로 접종하고, 접종한지 24, 48, 72 및 96 시간 후 반정량적 RT-PCR을 수행하여 관찰하였다. 도 11의 (A)에 나타낸 바와 같이, 상기 시간에서 관찰한 각각의 고춧잎들에서 CaLecRK1 유전자가 억제됨을 확인할 수 있다. 바이러스 감염 후 24, 48, 72 및 96 시간 경과 후에는 TRV2 대조군에 비해 CaLecRK1를 억제시킨 고춧잎에서 CaLecRK1 유전자가 각각 30%, 70%, 92% 및 78% 억제되었다.Then, in order to observe the effects of CaLecRK1 genes at the molecular level, after which the inoculated plants and plant TRV2 vector (control) inhibited the CaLecRK1 to PMMoV-P 0, and inoculated 24, 48, 72 and 96 hours of semi-quantitative RT- PCR was performed to observe. As shown in FIG. 11A , CaLecRK1 gene is inhibited in each pepper leaf observed at the time. At 24, 48, 72 and 96 hours after virus infection, CaLecRK1 genes were inhibited by 30%, 70%, 92% and 78% in red pepper leaves which inhibited CaLecRK1 compared to TRV2 control.
또한 PMMoV-P0 접종 후, CaLecRK1를 억제시킨 고춧잎에서 초민감성 반응의 감소가 관찰됨에 따라(결과 3), 본 발명자들은 상기 PMMoV-P0로 접종 후 CaLecRK1 억제시킨 고춧잎들에서 시그널링에 관여하는 유전자들의 발현 수준을 반정량적 RT-PCR을 이용하여 측정하였다. 먼저, SA(salicylic acid) 시그널링에 관여하는 유전자들(CaPAD4, CaNPR1, CaPR1, CaPR2, CaPR4, CaPR5, CaPR10)을 측정하였다. 측정 결과 도 11의 (B) 내지 (K)에 나타낸 바와 같이, 상기 SA 시그널링에 관여하는 유전자들은 CaPAD4 유전자를 제외하고 CaLecRK1-억제시킨 고춧잎에서 발현이 억제되었다. 그리고 MeJA(Methyl jasmonate) 시그널링에 관여하는 유전자들(CaJAZ1, CaCOI1) 또한 CaLecRK1를 억제시킨 고춧잎에서 억제되었다. 그러나, 에틸렌(ethylene) 시그널링에 관여하는 유전자인 CaEIN3는 CaLecRK1를 억제시킨 고춧잎에서 발현이 억제되지 않았다. 상기의 결과로 CaLecRK1 유전자가 PMMoV-P0에 대한 반응에서 시그널링에 관여하는 대다수의 유전자들의 발현을 조절함을 알 수 있다.
Also PMMoV-P 0 after inoculation, as the reduction in ultra-sensitive reactions observed in pepper leaves were suppressed CaLecRK1 (result 3), the inventors have found that genes involved in signaling in then inoculated with the PMMoV-P 0 CaLecRK1 inhibition was pepper leaves Their expression level was measured using semiquantitative RT-PCR. First, genes involved in signaling SA ( caPAD4 , CaNPR1 , CaPR1 , CaPR2 , CaPR4 , CaPR5 , CaPR10 ) were measured. As a result of the measurement, as shown in FIGS. 11B to 11K, genes involved in SA signaling were suppressed in CaLecRK1 -suppressed pepper leaves except CaPAD4 gene. Genes involved in MeJA (Methyl jasmonate) signaling ( CaJAZ1 , CaCOI1 ) were also inhibited in CaLecRK1 inhibited pepper leaves . However, CaEIN3 , a gene involved in ethylene signaling, was not inhibited in red pepper leaves that inhibited CaLecRK1 . These results indicate that CaLecRK1 gene regulates the expression of the majority of genes involved in signaling in response to PMMoV -P 0 .
결과 7.
PMMoV-P0에 대한 저항성에서 CaLecRK1 유전자의 영향을 관찰하기 위해, PMMoV-P0 CP(coat protein) 유전자 프라이머쌍을 이용하여 반정량적 RT-PCR을 수행하였다. PMMoV-P0 CP 유전자의 축적은 바이러스 증식의 지표로써 이용된다. For in resistance to PMMoV-P 0 to observe the effect of CaLecRK1 gene, using the PMMoV-P 0 CP (coat protein ) gene primers was performed semi-quantitative RT-PCR. Accumulation of the PMMoV-P 0 CP gene is used as an indicator of viral proliferation.
먼저, PMMoV-P0을 CaLecRK1 억제시킨 식물 및 TRV2 벡터 식물(대조군)에 접종한 후, 바이러스 감염 72 시간 후 상기 식물들을 관찰하였다. 관찰 결과, CaLecRK1 발현의 억제 및 HR 병변의 감소는 CaLecRK1을 억제시킨 식물에서 관찰되었다. 이후, PMMoV-P0의 증식을 CP 유전자를 이용하여 반정량적 RT-PCR로써 확인하였다. 도 12에 나타낸 바와 같이, CaLecRK1 유전자의 발현이 55% 억제 되었을 때, PMMoV-P0 CP 유전자 전사의 축적은 TRV2 대조군에 비해 CaLecRK1 억제시킨 식물에서 5 배 증가되었다. 따라서 CaLecRK1의 억제는 PMMoV-P0 CP 유전자의 전사를 증가시키는 결과를 야기시킴을 확인하였다.First, PMMoV -P 0 was inoculated into CaLecRK1 inhibited plants and TRV2 vector plants (control), and then the plants were observed 72 hours after virus infection. As a result, inhibition of CaLecRK1 expression and reduction of HR lesions were observed in plants that inhibited CaLecRK1 . Thereafter, the proliferation of PMMoV-P 0 was confirmed by semi-quantitative RT-PCR using the CP gene. As shown in FIG. 12, when the expression of the CaLecRK1 gene was suppressed by 55%, the accumulation of PMMoV-P 0 CP gene transcription was increased by 5 times in CaLecRK1 inhibited plants compared to the TRV2 control group. Therefore, it was confirmed that inhibition of CaLecRK1 resulted in increased transcription of PMMoV -P 0 CP gene.
또한 PMMoV-P0의 전파 체계(systemic spreading)에 대한 CaLecRK1 억제 효과를 확인하기 위해, 본 발명자들은 CaLecRK1을 억제 및 비억제시킨 식물의 하부를 PMMoV-P0으로 감염시키고, 감염 10 일 후, 바이러스를 감염시키지 않은 각 식물의 상부에서 PMMoV-P0 CP 유전자의 축적을 RT-PCR을 이용하여 비교하였다. RT-PCR은 PMMoV-P0 CP 유전자의 프라이머로 수행하였다. RT-PCR 결과, PMMoV-P0 CP는 TRV2 식물에 비해 CaLecRK1을 억제시킨 식물에서 더 축적됨을 관찰할 수 있었다 (도 13의 (A)). 이후, CaLecRK1의 억제 및 PMMoV-P0 CP 축적을 확인하기 위해, 반정량적 RT-PCR을 수행하였다. PMMoV-P0 CP 유전자의 전사는 CaLecRK1을 억제시킨 식물에서 4 배 이상 축적되었다.(도 13의 (B)).In addition, CaLecRK1 for the systemic spreading of PMMoV -P 0 . In order to confirm the inhibitory effect, we infected the lower part of plants that inhibited and uninhibited CaLecRK1 with PMMoV -P 0 , and after 10 days of infection, the PMMoV-P 0 CP gene at the top of each plant not infected with the virus. The accumulation of was compared using RT-PCR. RT-PCR was performed with primers of PMMoV-P 0 CP gene. As a result of RT-PCR, PMMoV-P 0 CP was observed to accumulate more in CaLecRK1 inhibited plants compared to TRV2 plants (Fig. 13 (A)). Then, semi-quantitative RT-PCR was performed to confirm the inhibition of CaLecRK1 and PMMoV -P 0 CP accumulation. Transcription of the PMMoV -P 0 CP gene was accumulated more than four times in plants inhibiting CaLecRK1 (FIG. 13B).
또한 PMMoV-P0 접종에 따른 CaLecRK1에 의해 매개되는 방어 반응을 트리판 블루(trypan blue) 염색 및 DAB 염색으로 관찰하였다. PMMoV-P 0 The protective response mediated by CaLecRK1 following inoculation was observed by trypan blue staining and DAB staining.
먼저 CaLecRK1을 억제시킨 식물 및 TRV2 식물(대조군)을 PMMoV-P0로 감염시켰다. 감염 3 일 후, 상기 식물들을 트리판 블루 및 DAB로 염색하였다. 상기 염색으로 죽은 조직 또는 죽은 세포를 확인할 수 있다. 염색 후 식물들을 관찰한 결과, 도 14의 (A)에 나타낸 것과 같이 세포 죽음(cell death)은 TRV2 식물(대조군)에 비해 CaLecRK1을 억제시킨 식물에서 더 낮게 나타남을 확인할 수 있다. 이후, 상기 식물들로부터 CaLecRK1 억제 및 PMMoV-P0 CP 유전자의 축적을 반정량적 RT-PCR을 수행하여 확인하였다. RT-PCR 결과, CaLecRK1 유전자가 78% 억제 되었을 때, 세포 죽음이 감소되었으며, 그 결과로 PMMoV-P0 CP 유전자 전사의 축적이 2.7 배 증가되었다.(도 14의 (B)).First, plants inhibiting CaLecRK1 and TRV2 plants (control) were infected with PMMoV-P 0 . Three days after infection, the plants were stained with trypan blue and DAB. The staining can identify dead tissue or dead cells. As a result of observing plants after staining, as shown in FIG. 14A, cell death was lower in plants inhibiting CaLecRK1 than in TRV2 plants (control). Then, CaLecRK1 inhibition and accumulation of PMMoV -P 0 CP gene from the plants were confirmed by performing semiquantitative RT-PCR. As a result of RT-PCR, cell death was reduced when the CaLecRK1 gene was 78% inhibited, resulting in a 2.7-fold increase in the accumulation of PMMoV-P 0 CP gene transcription (FIG. 14B).
그리고, 산화 폭발(oxidative burst)하는 동안 ROS(reactive oxygen species)가 방출될 때 형성되는 분자인 H2O2는 DAB로 염색함으로써 시각화하였다. 그 결과, H2O2 생성은 TRV2 식물에 비해 CaLecRK1 억제시킨 식물에서 더 낮게 나타남을 확인할 수 있다(도 15의 (A)). 이후 상기 식물들로부터 CaLecRK1 억제 및 PMMoV-P0 CP 유전자의 축적을 반정량적 RT-PCR로 확인하였다. 측정 결과, CaLecRK1 유전자는 80% 억제 되었을 때, PMMoV-P0 CP 유전자의 전사는 5 배 증가되었다 (도 15의 (B)).In addition, H 2 O 2 , a molecule formed when ROS (reactive oxygen species) is released during an oxidative burst, was visualized by staining with DAB. As a result, it can be seen that H 2 O 2 production is lower in CaLecRK1 inhibited plants than in TRV2 plants (FIG. 15 (A)). Thereafter, CaLecRK1 inhibition and accumulation of PMMoV -P 0 CP gene from the plants were confirmed by semiquantitative RT-PCR. As a result, when the CaLecRK1 gene was 80% inhibited, the transcription of the PMMoV -P 0 CP gene was increased five times (Fig. 15 (B)).
상기의 결과들을 통해, CaLecRK1은 PCD(programmed cell death) 및 H2O2 생성의 조절을 통한 PMMoV-P0에 대한 식물의 저항성을 위해 요구되는 것으로 사료된다.
Based on the above results, CaLecRK1 seems to be required for plant resistance to PMMoV-P 0 through the regulation of programmed cell death (PCD) and H 2 O 2 production.
<110> Korea University Industrial & Academic Collaboration Foundation <120> CaLecRK1 gene from hot pepper concerned in defense response of plants and use thereof <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 2433 <212> DNA <213> Artificial Sequence <220> <223> Capsicum annuum lectin receptor kinase 1 <400> 1 acatgggcat gattgtgttt gtcacttcca attttttatt ttacacaatc ccaacgtgct 60 ttaaaaacct tctttttatc aaccctccat gtatcttcct ctcataatcc tcacttctct 120 atacttcatt tcactacatg aaaacaaaaa aatgaaattc ttgacaccca aaatcatcag 180 tatcttcata tttttctctt gtatacaatc catatcacaa gccaagatca aaaaatttga 240 caaacaatat ggtgatcctt ttgatcatac atatactccc atatttgaaa tcaaacatcc 300 tgcacaaatc agcaacctag ctcttcaaat caccccagac accgcgtctt ctgcttatca 360 aatgttcaat aactcaggtc gaatcctgtt gaaacgacca ttcagattgt gggatagtag 420 tcatgatgac ggagttgagg atctttcaag gttggcgtct ttcaacactt cttttttagt 480 aaacatttac aggccaaaaa atgacacacc agctgaagga ttggcattct tgatttgtcc 540 tgatttagac ctgccaaaaa acagtcaggg ccagtactta ggcctgacaa atagtactac 600 tgatggcgac gcttccaaca ggattatcgc ggttgagcta gacacgttca agcaagattt 660 tgacatcgat gacaaccaca ttggaattga tttacacagt atagattcta ttaaatcgga 720 gtcactgact ccgcatggaa ttcaactagc accaataggt gcaagatttt acaacatttg 780 gatacaatat gacggaatca agaaagtact tgatgtgtac attgttgaac aaatggggaa 840 aaatggttca acaccaccta gaccaaatga tccaatatta acacacaatc ttgatttaag 900 aaaatttgta aatcaagaat catactttgg gttctcagca tcaacaggcc atttcaatca 960 gttgaattgt gtgttgagat ggaatttaac agttgaatat tttcaagaaa agaatcatgg 1020 tttgataatt ggattaggtg ttggtgtacc tatagtagtt gtgttaatga ttttgtttgg 1080 gtattttggt tacttttatt ataagaaaaa aaggggtgat aggtcacaat ctaatatatt 1140 gggtgcatta aagagtttac ctggtatgcc tagagatttt gagtttaaag aattgaaaaa 1200 agctactaat aattttgatg aaaaaaataa acttggtgaa ggtggatatg gagttgttta 1260 caaaggcaat ttggttgatg aaaaattgga aattgcagtg aagtggtttt ctagagaaag 1320 tatcaaaggt gaagatgatt tcttggctga gttgacaatt atcaatcgtt taaggcataa 1380 acatcttgtc aaattacttg gatggagcca taagcatgga aagctactac ttgtttatga 1440 gtacatgcca aatggtagcc tagacaaaca tctcttctca gcgccagata aagaaccact 1500 cagctggtgc gtccgctaca acattgtatc aggcgtcgcg tcagccctgc actatctgca 1560 caatgagtac gaacagaagg tggtccatcg cgatctcaag gcgaacaaca tcatgctcga 1620 ctcaaacttc aatgcacgcc ttggggattt tggcctagca cgagcaattg acaatgagaa 1680 gacctcgtat gctgatgagg ccgagggggt gcttggcacg atggggtaca tcgcgccaga 1740 gtgcttccac actggaaaag ctactcaaca ttctgatgtc tatgcatttg gagcagtgtt 1800 gttggaagta gtatgtggcc aaagacctgg aaccaaagtt aatggctttc aactccttgt 1860 tgattgggtt tggttcttgc atcgcgatgg aagaatcctc gaagctgttg acaggaggct 1920 cggggatgat tacgtagctg aagaagcaaa gaggttgcta ctacttactc tagcttgctc 1980 acatccaatc gcgagtgaac gaccgaccac acaaactata gttcaaatta tatcaggatc 2040 agtgccagca ccagaagttc caccattcaa gccatcattt gtgtggcctt ctatggttcc 2100 agttgatata gaatcgagca tcgtcgatac aatatccatc acaacacctc agttcagttc 2160 agagaacaac agtattgagt atctaagcaa gtagagatag ctatagcagc atacatatta 2220 ccaacaggaa aaaaaaatta attaacttga ctttgatttc ccttttttaa tgtttttttc 2280 actctgtaat tatgttatat ggtgaggttg tcaaaagaat ttttctcttc cttcttgttt 2340 tgtttttctt ttgggctgca agtttgtaat tctgtaatga caagaacata aacaatgtat 2400 atttcttaga ccttaaaaaa aaaaaaaaaa aaa 2433 <210> 2 <211> 701 <212> PRT <213> Artificial Sequence <220> <223> Capsicum annuum lectin receptor kinase 1 <400> 2 Met Tyr Leu Pro Leu Ile Ile Leu Thr Ser Leu Tyr Phe Ile Ser Leu 1 5 10 15 His Glu Asn Lys Lys Met Lys Phe Leu Thr Pro Lys Ile Ile Ser Ile 20 25 30 Phe Ile Phe Phe Ser Cys Ile Gln Ser Ile Ser Gln Ala Lys Ile Lys 35 40 45 Lys Phe Asp Lys Gln Tyr Gly Asp Pro Phe Asp His Thr Tyr Thr Pro 50 55 60 Ile Phe Glu Ile Lys His Pro Ala Gln Ile Ser Asn Leu Ala Leu Gln 65 70 75 80 Ile Thr Pro Asp Thr Ala Ser Ser Ala Tyr Gln Met Phe Asn Asn Ser 85 90 95 Gly Arg Ile Leu Leu Lys Arg Pro Phe Arg Leu Trp Asp Ser Ser His 100 105 110 Asp Asp Gly Val Glu Asp Leu Ser Arg Leu Ala Ser Phe Asn Thr Ser 115 120 125 Phe Leu Val Asn Ile Tyr Arg Pro Lys Asn Asp Thr Pro Ala Glu Gly 130 135 140 Leu Ala Phe Leu Ile Cys Pro Asp Leu Asp Leu Pro Lys Asn Ser Gln 145 150 155 160 Gly Gln Tyr Leu Gly Leu Thr Asn Ser Thr Thr Asp Gly Asp Ala Ser 165 170 175 Asn Arg Ile Ile Ala Val Glu Leu Asp Thr Phe Lys Gln Asp Phe Asp 180 185 190 Ile Asp Asp Asn His Ile Gly Ile Asp Leu His Ser Ile Asp Ser Ile 195 200 205 Lys Ser Glu Ser Leu Thr Pro His Gly Ile Gln Leu Ala Pro Ile Gly 210 215 220 Ala Arg Phe Tyr Asn Ile Trp Ile Gln Tyr Asp Gly Ile Lys Lys Val 225 230 235 240 Leu Asp Val Tyr Ile Val Glu Gln Met Gly Lys Asn Gly Ser Thr Pro 245 250 255 Pro Arg Pro Asn Asp Pro Ile Leu Thr His Asn Leu Asp Leu Arg Lys 260 265 270 Phe Val Asn Gln Glu Ser Tyr Phe Gly Phe Ser Ala Ser Thr Gly His 275 280 285 Phe Asn Gln Leu Asn Cys Val Leu Arg Trp Asn Leu Thr Val Glu Tyr 290 295 300 Phe Gln Glu Lys Asn His Gly Leu Ile Ile Gly Leu Gly Val Gly Val 305 310 315 320 Pro Ile Val Val Val Leu Met Ile Leu Phe Gly Tyr Phe Gly Tyr Phe 325 330 335 Tyr Tyr Lys Lys Lys Arg Gly Asp Arg Ser Gln Ser Asn Ile Leu Gly 340 345 350 Ala Leu Lys Ser Leu Pro Gly Met Pro Arg Asp Phe Glu Phe Lys Glu 355 360 365 Leu Lys Lys Ala Thr Asn Asn Phe Asp Glu Lys Asn Lys Leu Gly Glu 370 375 380 Gly Gly Tyr Gly Val Val Tyr Lys Gly Asn Leu Val Asp Glu Lys Leu 385 390 395 400 Glu Ile Ala Val Lys Trp Phe Ser Arg Glu Ser Ile Lys Gly Glu Asp 405 410 415 Asp Phe Leu Ala Glu Leu Thr Ile Ile Asn Arg Leu Arg His Lys His 420 425 430 Leu Val Lys Leu Leu Gly Trp Ser His Lys His Gly Lys Leu Leu Leu 435 440 445 Val Tyr Glu Tyr Met Pro Asn Gly Ser Leu Asp Lys His Leu Phe Ser 450 455 460 Ala Pro Asp Lys Glu Pro Leu Ser Trp Cys Val Arg Tyr Asn Ile Val 465 470 475 480 Ser Gly Val Ala Ser Ala Leu His Tyr Leu His Asn Glu Tyr Glu Gln 485 490 495 Lys Val Val His Arg Asp Leu Lys Ala Asn Asn Ile Met Leu Asp Ser 500 505 510 Asn Phe Asn Ala Arg Leu Gly Asp Phe Gly Leu Ala Arg Ala Ile Asp 515 520 525 Asn Glu Lys Thr Ser Tyr Ala Asp Glu Ala Glu Gly Val Leu Gly Thr 530 535 540 Met Gly Tyr Ile Ala Pro Glu Cys Phe His Thr Gly Lys Ala Thr Gln 545 550 555 560 His Ser Asp Val Tyr Ala Phe Gly Ala Val Leu Leu Glu Val Val Cys 565 570 575 Gly Gln Arg Pro Gly Thr Lys Val Asn Gly Phe Gln Leu Leu Val Asp 580 585 590 Trp Val Trp Phe Leu His Arg Asp Gly Arg Ile Leu Glu Ala Val Asp 595 600 605 Arg Arg Leu Gly Asp Asp Tyr Val Ala Glu Glu Ala Lys Arg Leu Leu 610 615 620 Leu Leu Thr Leu Ala Cys Ser His Pro Ile Ala Ser Glu Arg Pro Thr 625 630 635 640 Thr Gln Thr Ile Val Gln Ile Ile Ser Gly Ser Val Pro Ala Pro Glu 645 650 655 Val Pro Pro Phe Lys Pro Ser Phe Val Trp Pro Ser Met Val Pro Val 660 665 670 Asp Ile Glu Ser Ser Ile Val Asp Thr Ile Ser Ile Thr Thr Pro Gln 675 680 685 Phe Ser Ser Glu Asn Asn Ser Ile Glu Tyr Leu Ser Lys 690 695 700 <110> Korea University Industrial & Academic Collaboration Foundation <120> CaLecRK1 gene from hot pepper concerned in defense response of plants and use pretty <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 2433 <212> DNA <213> Artificial Sequence <220> <223> Capsicum annuum lectin receptor kinase 1 <400> 1 acatgggcat gattgtgttt gtcacttcca attttttatt ttacacaatc ccaacgtgct 60 ttaaaaacct tctttttatc aaccctccat gtatcttcct ctcataatcc tcacttctct 120 atacttcatt tcactacatg aaaacaaaaa aatgaaattc ttgacaccca aaatcatcag 180 tatcttcata tttttctctt gtatacaatc catatcacaa gccaagatca aaaaatttga 240 caaacaatat ggtgatcctt ttgatcatac atatactccc atatttgaaa tcaaacatcc 300 tgcacaaatc agcaacctag ctcttcaaat caccccagac accgcgtctt ctgcttatca 360 aatgttcaat aactcaggtc gaatcctgtt gaaacgacca ttcagattgt gggatagtag 420 tcatgatgac ggagttgagg atctttcaag gttggcgtct ttcaacactt cttttttagt 480 aaacatttac aggccaaaaa atgacacacc agctgaagga ttggcattct tgatttgtcc 540 tgatttagac ctgccaaaaa acagtcaggg ccagtactta ggcctgacaa atagtactac 600 tgatggcgac gcttccaaca ggattatcgc ggttgagcta gacacgttca agcaagattt 660 tgacatcgat gacaaccaca ttggaattga tttacacagt atagattcta ttaaatcgga 720 gtcactgact ccgcatggaa ttcaactagc accaataggt gcaagatttt acaacatttg 780 gatacaatat gacggaatca agaaagtact tgatgtgtac attgttgaac aaatggggaa 840 aaatggttca acaccaccta gaccaaatga tccaatatta acacacaatc ttgatttaag 900 aaaatttgta aatcaagaat catactttgg gttctcagca tcaacaggcc atttcaatca 960 gttgaattgt gtgttgagat ggaatttaac agttgaatat tttcaagaaa agaatcatgg 1020 tttgataatt ggattaggtg ttggtgtacc tatagtagtt gtgttaatga ttttgtttgg 1080 gtattttggt tacttttatt ataagaaaaa aaggggtgat aggtcacaat ctaatatatt 1140 gggtgcatta aagagtttac ctggtatgcc tagagatttt gagtttaaag aattgaaaaa 1200 agctactaat aattttgatg aaaaaaataa acttggtgaa ggtggatatg gagttgttta 1260 caaaggcaat ttggttgatg aaaaattgga aattgcagtg aagtggtttt ctagagaaag 1320 tatcaaaggt gaagatgatt tcttggctga gttgacaatt atcaatcgtt taaggcataa 1380 acatcttgtc aaattacttg gatggagcca taagcatgga aagctactac ttgtttatga 1440 gtacatgcca aatggtagcc tagacaaaca tctcttctca gcgccagata aagaaccact 1500 cagctggtgc gtccgctaca acattgtatc aggcgtcgcg tcagccctgc actatctgca 1560 caatgagtac gaacagaagg tggtccatcg cgatctcaag gcgaacaaca tcatgctcga 1620 ctcaaacttc aatgcacgcc ttggggattt tggcctagca cgagcaattg acaatgagaa 1680 gacctcgtat gctgatgagg ccgagggggt gcttggcacg atggggtaca tcgcgccaga 1740 gtgcttccac actggaaaag ctactcaaca ttctgatgtc tatgcatttg gagcagtgtt 1800 gttggaagta gtatgtggcc aaagacctgg aaccaaagtt aatggctttc aactccttgt 1860 tgattgggtt tggttcttgc atcgcgatgg aagaatcctc gaagctgttg acaggaggct 1920 cggggatgat tacgtagctg aagaagcaaa gaggttgcta ctacttactc tagcttgctc 1980 acatccaatc gcgagtgaac gaccgaccac acaaactata gttcaaatta tatcaggatc 2040 agtgccagca ccagaagttc caccattcaa gccatcattt gtgtggcctt ctatggttcc 2100 agttgatata gaatcgagca tcgtcgatac aatatccatc acaacacctc agttcagttc 2160 agagaacaac agtattgagt atctaagcaa gtagagatag ctatagcagc atacatatta 2220 ccaacaggaa aaaaaaatta attaacttga ctttgatttc ccttttttaa tgtttttttc 2280 actctgtaat tatgttatat ggtgaggttg tcaaaagaat ttttctcttc cttcttgttt 2340 tgtttttctt ttgggctgca agtttgtaat tctgtaatga caagaacata aacaatgtat 2400 atttcttaga ccttaaaaaa aaaaaaaaaa aaa 2433 <210> 2 <211> 701 <212> PRT <213> Artificial Sequence <220> <223> Capsicum annuum lectin receptor kinase 1 <400> 2 Met Tyr Leu Pro Leu Ile Ile Leu Thr Ser Leu Tyr Phe Ile Ser Leu 1 5 10 15 His Glu Asn Lys Lys Met Lys Phe Leu Thr Pro Lys Ile Ile Ser Ile 20 25 30 Phe Ile Phe Phe Ser Cys Ile Gln Ser Ile Ser Gln Ala Lys Ile Lys 35 40 45 Lys Phe Asp Lys Gln Tyr Gly Asp Pro Phe Asp His Thr Tyr Thr Pro 50 55 60 Ile Phe Glu Ile Lys His Pro Ala Gln Ile Ser Asn Leu Ala Leu Gln 65 70 75 80 Ile Thr Pro Asp Thr Ala Ser Ser Ala Tyr Gln Met Phe Asn Asn Ser 85 90 95 Gly Arg Ile Leu Leu Lys Arg Pro Phe Arg Leu Trp Asp Ser Ser His 100 105 110 Asp Asp Gly Val Glu Asp Leu Ser Arg Leu Ala Ser Phe Asn Thr Ser 115 120 125 Phe Leu Val Asn Ile Tyr Arg Pro Lys Asn Asp Thr Pro Ala Glu Gly 130 135 140 Leu Ala Phe Leu Ile Cys Pro Asp Leu Asp Leu Pro Lys Asn Ser Gln 145 150 155 160 Gly Gln Tyr Leu Gly Leu Thr Asn Ser Thr Thr Asp Gly Asp Ala Ser 165 170 175 Asn Arg Ile Ile Ala Val Glu Leu Asp Thr Phe Lys Gln Asp Phe Asp 180 185 190 Ile Asp Asp Asn His Ile Gly Ile Asp Leu His Ser Ile Asp Ser Ile 195 200 205 Lys Ser Glu Ser Leu Thr Pro His Gly Ile Gln Leu Ala Pro Ile Gly 210 215 220 Ala Arg Phe Tyr Asn Ile Trp Ile Gln Tyr Asp Gly Ile Lys Lys Val 225 230 235 240 Leu Asp Val Tyr Ile Val Glu Gln Met Gly Lys Asn Gly Ser Thr Pro 245 250 255 Pro Arg Pro Asn Asp Pro Ile Leu Thr His Asn Leu Asp Leu Arg Lys 260 265 270 Phe Val Asn Gln Glu Ser Tyr Phe Gly Phe Ser Ala Ser Thr Gly His 275 280 285 Phe Asn Gln Leu Asn Cys Val Leu Arg Trp Asn Leu Thr Val Glu Tyr 290 295 300 Phe Gln Glu Lys Asn His Gly Leu Ile Ile Gly Leu Gly Val Gly Val 305 310 315 320 Pro Ile Val Val Val Leu Met Ile Leu Phe Gly Tyr Phe Gly Tyr Phe 325 330 335 Tyr Tyr Lys Lys Lys Arg Gly Asp Arg Ser Gln Ser Asn Ile Leu Gly 340 345 350 Ala Leu Lys Ser Leu Pro Gly Met Pro Arg Asp Phe Glu Phe Lys Glu 355 360 365 Leu Lys Lys Ala Thr Asn Asn Phe Asp Glu Lys Asn Lys Leu Gly Glu 370 375 380 Gly Gly Tyr Gly Val Val Tyr Lys Gly Asn Leu Val Asp Glu Lys Leu 385 390 395 400 Glu Ile Ala Val Lys Trp Phe Ser Arg Glu Ser Ile Lys Gly Glu Asp 405 410 415 Asp Phe Leu Ala Glu Leu Thr Ile Ile Asn Arg Leu Arg His Lys His 420 425 430 Leu Val Lys Leu Leu Gly Trp Ser His Lys His Gly Lys Leu Leu Leu 435 440 445 Val Tyr Glu Tyr Met Pro Asn Gly Ser Leu Asp Lys His Leu Phe Ser 450 455 460 Ala Pro Asp Lys Glu Pro Leu Ser Trp Cys Val Arg Tyr Asn Ile Val 465 470 475 480 Ser Gly Val Ala Ser Ala Leu His Tyr Leu His Asn Glu Tyr Glu Gln 485 490 495 Lys Val Val His Arg Asp Leu Lys Ala Asn Asn Ile Met Leu Asp Ser 500 505 510 Asn Phe Asn Ala Arg Leu Gly Asp Phe Gly Leu Ala Arg Ala Ile Asp 515 520 525 Asn Glu Lys Thr Ser Tyr Ala Asp Glu Ala Glu Gly Val Leu Gly Thr 530 535 540 Met Gly Tyr Ile Ala Pro Glu Cys Phe His Thr Gly Lys Ala Thr Gln 545 550 555 560 His Ser Asp Val Tyr Ala Phe Gly Ala Val Leu Leu Glu Val Val Cys 565 570 575 Gly Gln Arg Pro Gly Thr Lys Val Asn Gly Phe Gln Leu Leu Val Asp 580 585 590 Trp Val Trp Phe Leu His Arg Asp Gly Arg Ile Leu Glu Ala Val Asp 595 600 605 Arg Arg Leu Gly Asp Asp Tyr Val Ala Glu Glu Ala Lys Arg Leu Leu 610 615 620 Leu Leu Thr Leu Ala Cys Ser His Pro Ile Ala Ser Glu Arg Pro Thr 625 630 635 640 Thr Gln Thr Ile Val Gln Ile Ile Ser Gly Ser Val Pro Ala Pro Glu 645 650 655 Val Pro Pro Phe Lys Pro Ser Phe Val Trp Pro Ser Met Val Pro Val 660 665 670 Asp Ile Glu Ser Ser Ile Val Asp Thr Ile Ser Ile Thr Thr Pro Gln 675 680 685 Phe Ser Ser Glu Asn Asn Ser Ile Glu Tyr Leu Ser Lys 690 695 700
Claims (10)
Caylic lectin receptor phosphorylation 1 ( CaLecRK1 ) gene having a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 2.
According to claim 1, wherein the gene is pepper lectin receptor phosphorylation 1 ( CaLecRK1 ) gene, characterized in that having a nucleotide sequence of SEQ ID NO: 1.
Calicectin receptor 1 ( CaLecRK1 ) protein having the amino acid sequence of SEQ ID NO: 2.
The recombinant vector which introduce | transduced the CaLecRK1 gene of Claim 1 or 2.
Plant transformed with the recombinant vector of claim 4.
A composition for increasing infection resistance of a plant comprising the expression inhibitor of the CaLecRK1 gene of claim 1 or 2 as an active ingredient.
According to claim 6, wherein the expression inhibitor is a composition for increasing infection resistance of plants, characterized in that the viral vector for VIGS introduced CaLecRK1 gene.
8. The composition for increasing infection resistance of a plant according to claim 7, wherein the viral vector for VIGS into which the CaLecRK1 gene is introduced is pTRV2 :: CaLecRK1 disclosed in FIG.
The composition of claim 6, wherein the infection of the plant is caused by PMMoV-P 0 .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100066561A KR101251615B1 (en) | 2010-07-09 | 2010-07-09 | CaLecRK1 gene from hot pepper concerned in defense response of plants and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100066561A KR101251615B1 (en) | 2010-07-09 | 2010-07-09 | CaLecRK1 gene from hot pepper concerned in defense response of plants and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120005876A true KR20120005876A (en) | 2012-01-17 |
KR101251615B1 KR101251615B1 (en) | 2013-04-08 |
Family
ID=45611827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100066561A KR101251615B1 (en) | 2010-07-09 | 2010-07-09 | CaLecRK1 gene from hot pepper concerned in defense response of plants and use thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101251615B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107653258A (en) * | 2017-11-16 | 2018-02-02 | 河南大学 | Application of the cotton GhLecRK1 genes in vegetable verticillium wilt resistance |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100834252B1 (en) | 2007-04-16 | 2008-05-30 | 고려대학교 산학협력단 | CM gene related to pepper resistance and transgenic plant using the same |
-
2010
- 2010-07-09 KR KR1020100066561A patent/KR101251615B1/en active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107653258A (en) * | 2017-11-16 | 2018-02-02 | 河南大学 | Application of the cotton GhLecRK1 genes in vegetable verticillium wilt resistance |
CN107653258B (en) * | 2017-11-16 | 2021-01-29 | 河南大学 | Application of cotton GhLecRK1 gene in plant verticillium wilt resistance |
Also Published As
Publication number | Publication date |
---|---|
KR101251615B1 (en) | 2013-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Checker et al. | Molecular and functional characterization of mulberry EST encoding remorin (MiREM) involved in abiotic stress | |
Ascenzi et al. | A drought-stress-inducible histone gene in Arabidopsis thaliana is a member of a distinct class of plant linker histone variants | |
Liu et al. | Phylogenetic analysis of barley WRKY proteins and characterization of HvWRKY1 and-2 as repressors of the pathogen-inducible gene HvGER4c | |
EP3318638A1 (en) | Nucleotide sequence for improving resistance against plant pathogens | |
JP2011519562A (en) | Transcriptional and post-transcriptional control of transcription factors for drought resistance | |
PL211212B1 (en) | Plant-derived resistance gene | |
CN105254726A (en) | ERF transcription factor related to plant stress resistance and encoding gene and application thereof | |
AU2019261797A1 (en) | Plants having enhanced abiotic stress resistance | |
US20150128304A1 (en) | Plant Body Showing Improved Resistance Against Environmental Stress and Method for Producing Same | |
Chung et al. | Capsicum annuum dehydrin, an osmotic-stress gene in hot pepper plants | |
Yin et al. | Role of OsWAK124, a rice wall-associated kinase, in response to environmental heavy metal stresses | |
CN102449154B (en) | Methods and compositions for stress tolerance in plants | |
CN103911384A (en) | Gene for controlling Sclerotinia sclerotiorum (Lib.) de Bary of Brassica napus L. and use thereof | |
KR101251615B1 (en) | CaLecRK1 gene from hot pepper concerned in defense response of plants and use thereof | |
US10221427B2 (en) | Gene capable of enhancing salicylic acid-induced cell death in a plant cell and contributing to resistance to the fungal virulence factor deoxynivalenol, resistance to fusarium fungi and fusarium head blight disease, and a recombinant construct including the gene | |
CN109593782B (en) | Utilizing N. benthamiana HIR3s gene to obtain disease-resistant plants and use of the gene | |
Ye et al. | Cotton genes GhMML1 and GhMML2 control trichome branching when ectopically expressed in tobacco | |
CN104774847B (en) | Yangbi bulla walnut Pro-rich GFP JsPRP1 and application | |
EP2208788A1 (en) | MANIPULATION OF THE FUNCTION OF AtDBP1 IN ORDER TO GENERATE POTYVIRUS RESISTANCE | |
KR101028113B1 (en) | CaH1 gene and its use in red pepper involved in growth growth, flame resistance and aging regulation | |
CN106497932A (en) | Preventing and treating Meloidogyne incognita related gene Misp12 and its application | |
KR100915579B1 (en) | CaBtf3 gene from hot pepper concerned in defense response and development of plants and use thereof | |
CN114349834B (en) | Cysteine-rich toxic protein, expression vector and application thereof in inhibiting plant virus infection | |
JP5833827B2 (en) | Genes that increase oil and fat productivity of plants and methods for using the same | |
KR100506399B1 (en) | Pathogen-inducible NgCDM1 protein isolated from Nocotiana glutinosa, a gene and a promoter coding the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20100709 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20120221 Patent event code: PE09021S01D |
|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20121130 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20120221 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
X091 | Application refused [patent] | ||
AMND | Amendment | ||
PX0901 | Re-examination |
Patent event code: PX09011S01I Patent event date: 20121130 Comment text: Decision to Refuse Application Patent event code: PX09012R01I Patent event date: 20120605 Comment text: Amendment to Specification, etc. |
|
E90F | Notification of reason for final refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20130108 Patent event code: PE09021S02D |
|
AMND | Amendment | ||
PX0701 | Decision of registration after re-examination |
Patent event date: 20130311 Comment text: Decision to Grant Registration Patent event code: PX07013S01D Patent event date: 20130219 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20121227 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20121130 Comment text: Decision to Refuse Application Patent event code: PX07011S01I Patent event date: 20120605 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I |
|
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20130401 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20130402 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20160225 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20160225 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170328 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20170328 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180403 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20180403 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20190401 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20190401 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20200401 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20210630 Start annual number: 9 End annual number: 9 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20230112 |